A	O
Galectin	B-GP
from	O
the	O
Kuruma	B-OG
Shrimp	I-OG
(	O
Marsupenaeus	B-OG
japonicus	I-OG
)	O
Functions	O
as	O
an	O
Opsonin	O
and	O
Promotes	O
Bacterial	O
Clearance	O
from	O
Hemolymph	O

Competing	O
Interests	O
:	O
The	O
authors	O
have	O
declared	O
that	O
no	O
competing	O
interests	O
exist	O
.	O

Conceived	O
and	O
designed	O
the	O
experiments	O
:	O
JXW	O
LW	O
XFZ	O
.	O

Performed	O
the	O
experiments	O
:	O
LW	O
XZS	O
SX	O
XWZ	O
.	O

Analyzed	O
the	O
data	O
:	O
LW	O
JXW	O
GRV	O
.	O

Contributed	O
reagents	O
/	O
materials	O
/	O
analysis	O
tools	O
:	O
JXW	O
XFZ	O
.	O

Wrote	O
the	O
paper	O
:	O
LW	O
XZS	O
JXW	O
GRV	O
.	O

Galectins	B-GP
are	O
a	O
lectin	B-GP
family	O
characterized	O
by	O
a	O
conserved	O
sequence	O
motif	O
in	O
the	O
carbohydrate	O
recognition	O
domain	O
,	O
which	O
preferential	O
binds	O
to	O
galactosyl	O
moieties	O
.	O

However	O
,	O
few	O
studies	O
about	O
the	O
biological	O
roles	O
of	O
galectins	B-GP
in	O
invertebrates	B-OG
have	O
been	O
reported	O
except	O
for	O
the	O
galectin	B-GP
(	O
CvGal1	B-GP
)	O
from	O
the	O
eastern	B-OG
oyster	I-OG
Crassostrea	B-OG
virginica	I-OG
.	O

Furthermore	O
,	O
galectins	B-GP
have	O
been	O
described	O
in	O
only	O
a	O
few	O
crustacean	B-OG
species	O
,	O
and	O
no	O
functional	O
studies	O
have	O
been	O
reported	O
so	O
far	O
.	O

In	O
this	O
study	O
,	O
we	O
identified	O
and	O
functionally	O
characterized	O
a	O
galectin	B-GP
from	O
the	O
kuruma	B-OG
shrimp	I-OG
Marsupenaeus	B-OG
japonicus	I-OG
,	O
which	O
we	O
designated	O
MjGal	B-GP
.	O

Upon	O
Vibrio	B-OG
anguillarum	I-OG
challenge	O
,	O
expression	O
of	O
MjGal	B-GP
was	O
up	O
-	O
regulated	O
mostly	O
in	O
hemocytes	O
and	O
hepatopancreas	O
,	O
and	O
the	O
protein	O
bound	O
to	O
both	O
Gram	O
-	O
positive	O
and	O
Gram	B-OG
-	I-OG
negative	I-OG
bacteria	I-OG
through	O
the	O
recognition	O
of	O
lipoteichoic	O
acid	O
(	O
LTA	O
)	O
or	O
lipopolysaccharide	O
(	O
LPS	O
),	O
respectively	O
.	O

By	O
also	O
binding	O
to	O
the	O
shrimp	B-OG
hemocyte	O
surface	O
,	O
MjGal	B-GP
functions	O
as	O
an	O
opsonin	O
for	O
microbial	O
pathogens	O
,	O
promoting	O
their	O
phagocytosis	O
.	O

Further	O
,	O
as	O
shown	O
by	O
RNA	O
interference	O
,	O
MjGal	B-GP
participates	O
in	O
clearance	O
of	O
bacteria	B-OG
from	O
circulation	O
,	O
and	O
thereby	O
contributes	O
to	O
the	O
shrimp	B-OG
’	O
s	O
immune	O
defense	O
against	O
infectious	O
challenge	O
.	O

Elucidation	O
of	O
functional	O
and	O
mechanistic	O
aspects	O
of	O
shrimp	B-OG
immunity	O
will	O
enable	O
the	O
development	O
of	O
novel	O
strategies	O
for	O
intervention	O
in	O
infectious	B-DS
diseases	I-DS
currently	O
affecting	O
the	O
shrimp	B-OG
farming	O
industry	O
worldwide	O
.	O

Introduction	O

Invertebrates	B-OG
lack	O
the	O
typical	O
adaptive	O
immune	O
responses	O
of	O
vertebrates	B-OG
but	O
are	O
endowed	O
with	O
effective	O
defense	O
mechanisms	O
against	O
infectious	O
challenge	O
[	O
1	O
].	O

They	O
comprise	O
both	O
cellular	O
and	O
humoral	O
responses	O
mediated	O
by	O
multiple	O
soluble	O
factors	O
and	O
cell	B-GP
-	I-GP
associated	I-GP
receptors	I-GP
that	O
can	O
recognize	O
pathogens	O
and	O
lead	O
to	O
effector	O
functions	O
,	O
including	O
opsonization	O
,	O
phagocytosis	O
,	O
coagulation	O
cascades	O
and	O
expression	O
of	O
antimicrobial	B-GP
peptides	I-GP
[	O
2	O
],	O
[	O
3	O
].	O

Pathogen	O
recognition	O
functions	O
that	O
involve	O
protein	O
-	O
carbohydrate	O
interactions	O
are	O
mostly	O
mediated	O
by	O
both	O
soluble	O
and	O
cell	O
-	O
associated	O
lectins	B-GP
,	O
which	O
are	O
critical	O
components	O
of	O
the	O
innate	O
immune	O
responses	O
in	O
both	O
vertebrates	B-OG
and	O
invertebrates	B-OG
[	O
4	O
].	O

Based	O
on	O
their	O
carbohydrate	O
specificity	O
,	O
divalent	O
cation	O
requirements	O
,	O
presence	O
of	O
conserved	O
sequence	O
motifs	O
in	O
their	O
carbohydrate	O
binding	O
domains	O
(	O
CRDs	O
),	O
and	O
most	O
recently	O
their	O
structural	O
folds	O
,	O
animal	B-OG
lectins	B-GP
have	O
classified	O
into	O
several	O
families	O
such	O
as	O
C	O
-,	O
F	O
-,	O
I	O
-	O
and	O
P	B-GP
-	I-GP
type	I-GP
lectins	I-GP
,	O
ficolins	B-GP
and	O
galectins	B-GP
.	O

Among	O
these	O
,	O
the	O
galectins	B-GP
,	O
formerly	O
known	O
as	O
S	B-GP
-	I-GP
type	I-GP
lectins	I-GP
,	O
constitute	O
a	O
multifunctional	O
albeit	O
structurally	O
conserved	O
family	O
of	O
β	B-GP
-	I-GP
galactoside	I-GP
-	I-GP
binding	I-GP
proteins	I-GP
,	O
which	O
contain	O
one	O
or	O
more	O
CRDs	O
per	O
subunit	O
sharing	O
a	O
conserved	O
sequence	O
motif	O
,	O
and	O
are	O
widely	O
distributed	O
among	O
eukaryotic	O
taxa	O
[	O
5	O
].	O

In	O
mammals	B-OG
,	O
up	O
to	O
15	O
distinct	O
galectins	B-GP
(	O
galectin	B-GP
-	I-GP
1	I-GP
to	O
15	O
)	O
have	O
been	O
described	O
that	O
fall	O
into	O
three	O
structural	O
types	O
:	O
proto	O
type	O
,	O
with	O
one	O
CRD	O
per	O
subunit	O
and	O
mostly	O
form	O
non	O
-	O
covalently	O
-	O
bound	O
dimers	O
,	O
the	O
chimera	O
type	O
,	O
also	O
with	O
one	O
CRD	O
and	O
an	O
N	O
-	O
terminal	O
polypeptide	O
extension	O
that	O
enables	O
subunit	O
oligomerization	O
into	O
trimers	O
and	O
pentamers	O
,	O
and	O
the	O
tandem	O
repeat	O
type	O
,	O
in	O
which	O
two	O
CRDs	O
are	O
covalently	O
joined	O
by	O
a	O
linker	O
peptide	O
[	O
6	O
].	O

Initially	O
described	O
as	O
mediating	O
embryogenesis	O
and	O
development	O
by	O
binding	O
to	O
endogenous	O
glycans	O
,	O
in	O
recent	O
years	O
galectins	B-GP
have	O
been	O
shown	O
as	O
key	O
regulators	O
of	O
immune	O
homeostasis	O
[	O
7	O
]–[	O
12	O
].	O

More	O
recently	O
,	O
however	O
,	O
the	O
elucidation	O
of	O
their	O
roles	O
in	O
multiple	O
aspects	O
of	O
innate	O
immune	O
responses	O
of	O
vertebrates	B-OG
has	O
included	O
the	O
direct	O
recognition	O
of	O
microbial	O
pathogens	O
and	O
function	O
as	O
pattern	B-GP
recognition	I-GP
receptors	I-GP
[	O
13	O
].	O

Thus	O
,	O
in	O
addition	O
to	O
recognizing	O
endogenous	O
‘	O
self	O
’	O
glycans	O
,	O
galectins	B-GP
can	O
recognize	O
microbe	B-OG
-	O
associated	O
molecular	O
patterns	O
consisting	O
of	O
similar	O
‘	O
non	O
-	O
self	O
’	O
carbohydrate	O
moieties	O
[	O
14	O
].	O

In	O
invertebrates	B-OG
,	O
galectins	B-GP
are	O
thought	O
to	O
participate	O
in	O
biological	O
processes	O
that	O
are	O
common	O
to	O
those	O
from	O
vertebrates	B-OG
based	O
on	O
‘	O
self	O
’	O
and	O
‘	O
non	O
-	O
self	O
’	O
recognition	O
described	O
above	O
.	O

However	O
,	O
relatively	O
few	O
studies	O
about	O
the	O
biological	O
roles	O
of	O
galectins	B-GP
in	O
invertebrates	B-OG
have	O
been	O
reported	O
.	O

A	O
galectin	B-GP
(	O
CvGal1	B-GP
)	O
of	O
unique	O
CRD	O
organization	O
from	O
the	O
eastern	B-OG
oyster	I-OG
Crassostrea	B-OG
virginica	I-OG
,	O
can	O
recognize	O
a	O
large	O
number	O
of	O
environmental	O
bacterial	O
species	O
and	O
strains	O
,	O
as	O
well	O
as	O
phytoplankton	B-OG
microalgae	B-OG
[	O
15	O
].	O

Furthermore	O
,	O
CvGal1	B-GP
is	O
up	O
-	O
regulated	O
by	O
infectious	O
challenge	O
with	O
trophozoites	O
from	O
the	O
parasite	O
Perkinsus	B-OG
marinus	I-OG
,	O
and	O
promotes	O
their	O
phagocytosis	O
by	O
binding	O
both	O
to	O
the	O
hemocyte	O
surface	O
(‘	O
self	O
’)	O
glycans	O
as	O
well	O
as	O
the	O
parasite	O
surface	O
(‘	O
non	O
-	O
self	O
’)	O
sugars	O
[	O
15	O
],	O
[	O
16	O
].	O

The	O
parasite	O
glycans	O
recognized	O
by	O
CvGal1	B-GP
are	O
structurally	O
different	O
from	O
those	O
recognized	O
on	O
the	O
oyster	B-OG
hemocytes	O
[	O
16	O
],	O
[	O
17	O
],	O
and	O
as	O
an	O
example	O
of	O
carbohydrate	O
-	O
based	O
molecular	O
mimicry	O
the	O
interactions	O
with	O
CvGal1	B-GP
facilitate	O
host	O
entry	O
by	O
the	O
parasite	O
[	O
13	O
],	O
[	O
14	O
],	O
[	O
18	O
].	O

A	O
similar	O
galectin	B-GP
(	O
McGal	B-GP
)	O
that	O
is	O
upregulated	O
by	O
microbial	O
challenge	O
and	O
can	O
recognize	O
microbial	O
pathogens	O
and	O
parasites	O
was	O
later	O
described	O
in	O
the	O
Manila	B-OG
clam	I-OG
Ruditapes	B-OG
philippinarum	I-OG
[	O
19	O
].	O

As	O
the	O
consumer	O
demand	O
for	O
farmed	O
shrimp	B-OG
has	O
continued	O
to	O
increase	O
worldwide	O
,	O
so	O
has	O
the	O
rate	O
of	O
infectious	B-DS
disease	I-DS
in	O
the	O
aquaculture	O
industry	O
settings	O
,	O
and	O
there	O
is	O
an	O
urgent	O
need	O
to	O
address	O
mechanistic	O
questions	O
concerning	O
the	O
shrimp	B-OG
immune	O
responses	O
to	O
microbial	O
pathogens	O
.	O

Although	O
various	O
aspects	O
of	O
the	O
roles	O
of	O
antimicrobial	B-GP
peptides	I-GP
,	O
C	B-GP
-	I-GP
type	I-GP
lectins	I-GP
,	O
and	O
other	O
immune	O
factors	O
have	O
been	O
characterized	O
in	O
considerable	O
detail	O
[	O
20	O
]–[	O
22	O
],	O
galectins	B-GP
have	O
been	O
described	O
in	O
only	O
a	O
few	O
crustacean	B-OG
species	O
[	O
23	O
],	O
and	O
no	O
functional	O
studies	O
have	O
been	O
reported	O
so	O
far	O
.	O

In	O
this	O
study	O
,	O
we	O
identified	O
and	O
characterized	O
a	O
galectin	B-GP
from	O
the	O
kuruma	B-OG
shrimp	I-OG
Marsupenaeus	B-OG
japonicus	I-OG
,	O
which	O
we	O
designated	O
MjGal	B-GP
(	O
Marsupenaeus	B-OG
japonicus	I-OG
galectin	B-GP
).	O

The	O
expression	O
of	O
MjGal	B-GP
is	O
up	O
-	O
regulated	O
upon	O
bacterial	O
challenge	O
,	O
and	O
the	O
protein	O
bind	O
to	O
bacteria	B-OG
through	O
the	O
recognition	O
of	O
lipoteichoic	O
acid	O
(	O
LTA	O
)	O
or	O
lipopolysaccharide	O
(	O
LPS	O
).	O

By	O
also	O
binding	O
to	O
the	O
shrimp	B-OG
hemocyte	O
surface	O
,	O
MjGal	B-GP
functions	O
as	O
an	O
opsonin	O
for	O
microbial	O
pathogens	O
,	O
promoting	O
their	O
phagocytosis	O
and	O
clearance	O
from	O
circulation	O
,	O
and	O
thereby	O
contributing	O
to	O
the	O
shrimp	B-OG
’	O
s	O
immune	O
defense	O
against	O
infectious	O
challenge	O
.	O

Materials	O
and	O
Methods	O

Reagents	O
,	O
Virus	O
and	O
Bacterial	O
Strains	O

Peptidoglycan	O
(	O
PGN	O
)	O
(	O
Micrococcus	B-OG
luteus	I-OG
),	O
lipoteichoic	O
acids	O
(	O
LTA	O
)	O
(	O
Staphylococcus	B-OG
aureus	I-OG
)	O
and	O
lipopolysaccharide	O
(	O
LPS	O
)	O
(	O
Escherichia	B-OG
coli	I-OG
)	O
were	O
from	O
Sigma	O
(	O
St	O
.	O
Louis	O
,	O
MO	O
,	O
USA	O
).	O

All	O
other	O
reagents	O
and	O
chemicals	O
were	O
molecular	O
biology	O
grade	O
or	O
obtained	O
at	O
the	O
highest	O
purity	O
available	O
from	O
Sangon	O
Biotech	O
(	O
Shanghai	O
,	O
China	O
).	O
Staphylococcus	B-OG
aureus	I-OG
,	O
E	B-OG
.	I-OG
coli	I-OG
,	O
Bacillus	B-OG
megaterium	I-OG
,	O
B	B-OG
.	I-OG
subtilis	I-OG
,	O
B	B-OG
.	I-OG
thuringiensis	I-OG
,	O
Klebsiella	B-OG
pneumoniae	I-OG
,	O
Pseudomonas	B-OG
aeruginosa	I-OG
and	O
Vibrio	B-OG
anguillarum	I-OG
were	O
obtained	O
from	O
Shandong	O
University	O
Organism	O
Culture	O
Collection	O
(	O
SDMCC	O
),	O
and	O
cultured	O
in	O
our	O
laboratory	O
in	O
Luria	O
-	O
Bertani	O
medium	O
.	O

Animals	B-OG

Healthy	O
kuruma	B-OG
shrimp	I-OG
(	O
Marsupenaeus	B-OG
japonicus	I-OG
)	O
with	O
average	O
weight	O
of	O
6	O
–	O
10	O
g	O
each	O
were	O
obtained	O
from	O
a	O
shrimp	B-OG
market	O
in	O
Jinan	O
,	O
Shandong	O
province	O
,	O
China	O
.	O

The	O
shrimp	B-OG
feeding	O
with	O
the	O
commercial	O
diet	O
daily	O
were	O
acclimated	O
in	O
aerated	O
artificial	O
seawater	O
(	O
Salinity	O
22	O
%,	O
w	O
/	O
v	O
)	O
at	O
22	O
°	O
C	O
for	O
two	O
days	O
before	O
use	O
.	O

Immune	O
Challenge	O

For	O
the	O
bacterial	O
challenge	O
,	O
the	O
cultured	O
V	B-OG
.	I-OG
anguillarum	I-OG
were	O
collected	O
by	O
centrifugation	O
at	O
5	O
,	O
000	O
g	O
for	O
3	O
min	O
,	O
washed	O
trice	O
by	O
sterile	O
phosphate	O
buffered	O
saline	O
(	O
PBS	O
,	O
137	O
mM	O
NaCl	O
,	O
2	O
.	O
7	O
mM	O
KCl	O
,	O
10	O
mM	O
Na2HPO4	O
,	O
2	O
mM	O
KH2PO4	O
,	O
pH	O
7	O
.	O
4	O
),	O
resuspended	O
in	O
PBS	O
,	O
plated	O
for	O
colony	O
counting	O
,	O
and	O
the	O
bacterial	O
suspension	O
adjusted	O
to	O
2	O
×	O
108	O
cfu	O
/	O
ml	O
.	O

Fifty	O
µl	O
of	O
the	O
bacterial	O
suspension	O
containing	O
1	O
×	O
107	O
cfu	O
were	O
injected	O
into	O
each	O
shrimp	B-OG
intramuscularly	O
at	O
the	O
fourth	O
abdominal	O
segment	O
.	O

Control	O
animals	B-OG
were	O
injected	O
with	O
the	O
same	O
volume	O
of	O
PBS	O
alone	O
.	O

The	O
experimental	O
and	O
control	O
animals	B-OG
(	O
at	O
least	O
three	O
shrimp	B-OG
at	O
each	O
time	O
point	O
)	O
were	O
bled	O
at	O
0	O
,	O
2	O
,	O
6	O
,	O
12	O
,	O
24	O
,	O
48	O
h	O
after	O
challenge	O
.	O

Hemolymph	O
was	O
drawn	O
from	O
the	O
ventral	O
sinus	O
using	O
a	O
5	O
ml	O
sterile	O
syringe	O
fitted	O
with	O
a	O
26	O
-	O
gauge	O
needle	O
,	O
and	O
collected	O
into	O
1	O
ml	O
of	O
pre	O
-	O
cooled	O
anticoagulant	O
(	O
450	O
mM	O
NaCl	O
,	O
10	O
mM	O
KCl	O
,	O
10	O
mM	O
EDTA	O
,	O
10	O
mM	O
HEPES	O
,	O
pH	O
7	O
.	O
45	O
)	O
at	O
a	O
ratio	O
of	O
1	O
∶	O
1	O
,	O
and	O
immediately	O
centrifuged	O
at	O
600	O
g	O
for	O
10	O
min	O
at	O
4	O
°	O
C	O
to	O
separate	O
the	O
hemocytes	O
.	O

Subsequently	O
,	O
the	O
animals	B-OG
were	O
euthanized	O
and	O
dissected	O
,	O
and	O
heart	O
,	O
hepatopancreas	O
,	O
gills	O
,	O
stomach	O
and	O
intestine	O
tissues	O
were	O
collected	O
.	O

The	O
tissue	O
samples	O
and	O
hemocyte	O
pellet	O
were	O
immediately	O
processed	O
for	O
RNA	O
extraction	O
.	O

cDNA	O
Cloning	O
and	O
Sequence	O
Analysis	O
of	O
the	O
Shrimp	B-OG
Galectin	B-GP
(	O
MjGal	B-GP
)	O

A	O
sequence	O
analysis	O
of	O
the	O
shrimp	B-OG
EST	O
database	O
generated	O
in	O
our	O
laboratory	O
enabled	O
the	O
identification	O
of	O
a	O
transcript	O
that	O
showed	O
homology	O
to	O
members	O
of	O
the	O
galectin	B-GP
family	O
,	O
and	O
that	O
we	O
designated	O
as	O
MjGal	B-GP
.	O

To	O
clone	O
the	O
MjGal	B-GP
full	O
-	O
length	O
transcript	O
,	O
total	O
RNA	O
was	O
extracted	O
from	O
hepatopancreas	O
and	O
gills	O
of	O
shrimp	B-OG
using	O
the	O
Unizol	O
reagent	O
(	O
Biostar	O
,	O
Shanghai	O
,	O
China	O
).	O

The	O
cDNA	O
synthesis	O
was	O
conducted	O
with	O
the	O
SMART	O
cDNA	O
kit	O
(	O
BD	O
Biosciences	O
Clontech	O
)	O
following	O
the	O
manufacturer	O
’	O
s	O
instructions	O
.	O
MjGal	B-GP
was	O
amplified	O
with	O
a	O
set	O
of	O
primers	O
designed	O
on	O
the	O
identified	O
EST	O
sequence	O
as	O
follows	O
:	O
Gal	B-GP
F	O
(	O
5	O
′-	O
AAA	O
ACA	O
ACC	O
CAG	O
ACA	O
GCA	O
GTC	O
ATG	O
T	O
-	O
3	O
′)	O
and	O
Gal	B-GP
R	O
(	O
5	O
′-	O
GTA	O
TTT	O
CAA	O
GGC	O
CGT	O
ATA	O
AAC	O
CAC	O
TGC	O
A	O
-	O
3	O
′).	O

The	O
PCR	O
product	O
was	O
sequenced	O
,	O
and	O
BLAST	O
(	O
http	O
://	O
blast	O
.	O
ncbi	O
.	O
nlm	O
.	O
nih	O
.	O
gov	O
/	O
Blast	O
.	O
cgi	O
/)	O
was	O
used	O
for	O
a	O
similarity	O
sequence	O
analysis	O
,	O
ExPASy	O
(	O
http	O
://	O
cn	O
.	O
expasy	O
.	O
org	O
/)	O
to	O
deduce	O
the	O
protein	O
sequence	O
,	O
and	O
SMART	O
(	O
http	O
://	O
smart	O
.	O
embl	O
-	O
heidelberg	O
.	O
de	O
)	O
to	O
predict	O
the	O
domain	O
organization	O
.	O

Finally	O
,	O
the	O
MjGal	B-GP
sequence	O
was	O
aligned	O
with	O
representative	O
family	O
members	O
from	O
several	O
invertebrate	B-OG
species	O
and	O
a	O
phylogenetic	O
analysis	O
was	O
carried	O
out	O
using	O
the	O
MEGA	O
5	O
.	O
05	O
program	O
[	O
24	O
].	O

Semi	O
-	O
quantitative	O
RT	O
-	O
PCR	O
and	O
Quantitative	O
Real	O
Time	O
PCR	O
(	O
qRT	O
-	O
PCR	O
)	O

The	O
tissue	O
localization	O
of	O
the	O
MjGal	B-GP
transcripts	O
(	O
in	O
the	O
unchallenged	O
shrimp	B-OG
)	O
was	O
examined	O
by	O
semi	O
-	O
quantitative	O
RT	O
-	O
PCR	O
with	O
the	O
primers	O
Gal	B-GP
RT	O
F	O
(	O
5	O
′-	O
CCA	O
ACC	O
CTG	O
CTA	O
CTA	O
TGA	O
CC	O
-	O
3	O
′)	O
and	O
Gal	B-GP
RT	O
R	O
(	O
5	O
′-	O
ATC	O
CAC	O
TGC	O
TCC	O
CTG	O
ACC	O
-	O
3	O
′).	O

The	O
PCR	O
amplification	O
program	O
was	O
as	O
follows	O
:	O
94	O
°	O
C	O
for	O
5	O
min	O
followed	O
by	O
30	O
cycles	O
at	O
94	O
°	O
C	O
for	O
30	O
s	O
,	O
58	O
°	O
C	O
for	O
30	O
s	O
,	O
72	O
°	O
C	O
for	O
20	O
s	O
,	O
and	O
finally	O
72	O
°	O
C	O
for	O
10	O
min	O
.	O
β	B-GP
-	I-GP
actin	I-GP
was	O
used	O
as	O
internal	O
control	O
with	O
primers	O
β	B-GP
-	I-GP
actin	I-GP
F	O
(	O
5	O
′-	O
AGT	O
AGC	O
CGC	O
CCT	O
GGT	O
TGT	O
AGA	O
C	O
-	O
3	O
′)	O
and	O
β	B-GP
-	I-GP
actin	I-GP
R	O
(	O
5	O
′-	O
TTC	O
TCC	O
ATG	O
TCG	O
TCC	O
CAG	O
T	O
-	O
3	O
′).	O

The	O
MjGal	B-GP
expression	O
profiles	O
upon	O
V	B-OG
.	I-OG
anguillarum	I-OG
challenge	O
were	O
investigated	O
by	O
quantitative	O
real	O
-	O
time	O
PCR	O
(	O
qRT	O
-	O
PCR	O
)	O
with	O
the	O
same	O
primers	O
used	O
for	O
the	O
semi	O
-	O
quantitative	O
RT	O
-	O
PCR	O
.	O

The	O
qRT	O
-	O
PCR	O
was	O
carried	O
out	O
with	O
SYBR	O
Premix	O
Ex	O
Taq	O
(	O
Takara	O
,	O
Japan	O
)	O
following	O
the	O
manufacturer	O
’	O
s	O
instructions	O
,	O
in	O
a	O
real	O
-	O
time	O
thermal	O
cycler	O
(	O
Bio	O
-	O
Rad	O
,	O
USA	O
).	O

The	O
total	O
volume	O
was	O
10	O
µl	O
each	O
including	O
5	O
µl	O
of	O
Premix	O
Ex	O
Taq	O
,	O
2	O
µl	O
of	O
each	O
primer	O
(	O
1	O
mM	O
)	O
and	O
1	O
µl	O
of	O
cDNA	O
(	O
1	O
/	O
100	O
diluted	O
).	O

The	O
qRT	O
-	O
PCR	O
was	O
performed	O
at	O
95	O
°	O
C	O
for	O
5	O
min	O
,	O
followed	O
by	O
40	O
cycles	O
at	O
95	O
°	O
C	O
for	O
10	O
s	O
,	O
68	O
°	O
C	O
for	O
50	O
s	O
,	O
and	O
finally	O
,	O
melting	O
from	O
60	O
°	O
C	O
to	O
95	O
°	O
C	O
.	O

Every	O
sample	O
was	O
tested	O
in	O
triplicate	O
and	O
the	O
MjGal	B-GP
expression	O
levels	O
examined	O
by	O
the	O
comparative	O
CT	O
method	O
,	O
and	O
the	O
expression	O
patterns	O
upon	O
infectious	O
challenge	O
analyzed	O
by	O
2	O
−	O
ΔΔCT	O
.	O
The	O
unpaired	O
sample	O
t	O
-	O
test	O
was	O
used	O
for	O
statistic	O
analysis	O
,	O
and	O
the	O
significant	O
difference	O
was	O
accepted	O
at	O
P	O
<	O
0	O
.	O
05	O
.	O

Recombinant	O
Expression	O
of	O
MjGal	B-GP
and	O
Mutant	O
MjGalΔ102	O
–	O
106	O

For	O
recombinant	O
expression	O
of	O
MjGal	B-GP
,	O
the	O
sequence	O
was	O
amplified	O
using	O
the	O
primers	O
Gal	B-GP
exF	O
(	O
5	O
′-	O
TAC	O
TCA	O
CAT	O
ATG	O
(	O
Nde	B-GP
I	I-GP
)	O
ATG	O
TCA	O
GCA	O
CCA	O
GTG	O
TAC	O
AAC	O
-	O
3	O
′)	O
and	O
Gal	B-GP
exR	O
(	O
5	O
′-	O
TAC	O
TCA	O
CTC	O
GAG	O
(	O
Xho	B-GP
I	I-GP
)	O
TCA	O
TAT	O
ACC	O
CTC	O
CTC	O
CAG	O
CAA	O
GGG	O
-	O
3	O
′).	O

The	O
amplicon	O
and	O
the	O
expression	O
vector	O
[	O
pET30a	O
(+)]	O
were	O
digested	O
with	O
Nde	B-GP
I	I-GP
and	O
Xho	B-GP
I	I-GP
,	O
and	O
ligated	O
at	O
22	O
°	O
C	O
for	O
at	O
least	O
1	O
h	O
.	O

Recombinant	O
plasmids	O
were	O
transformed	O
into	O
E	B-OG
.	I-OG
coli	I-OG
BL21	I-OG
(	O
DE3	O
),	O
cultured	O
overnight	O
,	O
and	O
transferred	O
into	O
the	O
fresh	O
LB	O
medium	O
(	O
1	O
∶	O
100	O
)	O
containing	O
0	O
.	O
1	O
mg	O
/	O
ml	O
kanamycin	O
and	O
cultured	O
for	O
2	O
–	O
3	O
h	O
at	O
37	O
°	O
C	O
.	O

As	O
the	O
A600	O
of	O
the	O
culture	O
reached	O
OD	O
0	O
.	O
6	O
,	O
MjGal	B-GP
expression	O
was	O
induced	O
by	O
isopropyl	O
β	O
-	O
D	O
-	O
1	O
-	O
thiogalactopyranoside	O
(	O
IPTG	O
)	O
at	O
a	O
final	O
concentration	O
of	O
0	O
.	O
5	O
mM	O
,	O
followed	O
by	O
incubation	O
for	O
4	O
h	O
at	O
37	O
°	O
C	O
,	O
after	O
which	O
the	O
bacteria	B-OG
were	O
collected	O
by	O
centrifugation	O
at	O
6	O
,	O
000	O
g	O
for	O
15	O
min	O
,	O
and	O
resuspended	O
in	O
20	O
ml	O
of	O
PBS	O
containing	O
0	O
.	O
2	O
%	O
TritonX	O
-	O
100	O
.	O

The	O
bacteria	B-OG
were	O
lysed	O
by	O
sonication	O
,	O
centrifuged	O
at	O
12	O
,	O
000	O
g	O
for	O
15	O
min	O
,	O
the	O
supernatant	O
removed	O
,	O
and	O
the	O
pellet	O
containing	O
the	O
inclusion	O
bodies	O
washed	O
twice	O
with	O
buffer	O
A	O
(	O
50	O
mM	O
Tris	O
-	O
HCl	O
,	O
pH	O
8	O
.	O
0	O
,	O
5	O
mM	O
EDTA	O
)	O
followed	O
by	O
buffer	O
B	O
(	O
50	O
mM	O
Tris	O
-	O
HCl	O
pH	O
8	O
.	O
0	O
,	O
2	O
M	O
urea	O
,	O
5	O
mM	O
EDTA	O
),	O
and	O
finally	O
dissolved	O
in	O
20	O
ml	O
buffer	O
C	O
(	O
0	O
.	O
1	O
mM	O
Tris	O
-	O
HCl	O
,	O
pH	O
8	O
.	O
0	O
10	O
mM	O
DTT	O
,	O
8	O
M	O
urea	O
).	O

Refolding	O
of	O
the	O
recombinant	O
MjGal	B-GP
(	O
rMjGal	B-GP
)	O
protein	O
was	O
carried	O
out	O
by	O
one	O
step	O
of	O
dialysis	O
in	O
buffer	O
(	O
0	O
.	O
1	O
mM	O
Tris	O
-	O
HCl	O
pH	O
8	O
.	O
0	O
,	O
5	O
mM	O
EDTA	O
,	O
5	O
mM	O
cysteine	O
)	O
for	O
8	O
h	O
at	O
4	O
°	O
C	O
(	O
1	O
L	O
,	O
with	O
three	O
buffer	O
exchanges	O
;	O
24	O
h	O
total	O
dialysis	O
time	O
).	O

This	O
was	O
followed	O
by	O
centrifugation	O
at	O
12	O
,	O
000	O
g	O
for	O
15	O
min	O
at	O
4	O
°	O
C	O
to	O
remove	O
insoluble	O
proteins	O
,	O
and	O
the	O
rMjGal	B-GP
purified	O
by	O
His	O
Bind	O
resin	O
chromatograpy	O
.	O

A	O
recombinant	O
thioredoxin	B-GP
carrying	O
a	O
His	O
tag	O
[	O
Trx	B-GP
-	O
His	O
;	O
from	O
parent	O
vector	O
pET	O
-	O
32a	O
(+)]	O
was	O
expressed	O
and	O
purified	O
following	O
the	O
same	O
protocols	O
,	O
and	O
used	O
as	O
the	O
control	O
protein	O
.	O

In	O
order	O
to	O
rigorously	O
validate	O
the	O
function	O
of	O
MjGal	B-GP
,	O
a	O
mutant	O
MjGal	B-GP
was	O
constructed	O
by	O
deletion	O
of	O
five	O
residues	O
from	O
sites	O
102	O
to	O
106	O
and	O
recombinant	O
expressed	O
in	O
E	B-OG
.	I-OG
coli	I-OG
.	O

Primers	O
GalMtF	O
(	O
5	O
′-	O
GTG	O
ACC	O
ATC	O
CTC	O
TTC	O
AAG	O
ATT	O
GCC	O
GTG	O
AAT	O
-	O
3	O
′)	O
and	O
Gal	B-GP
exR	O
were	O
used	O
for	O
amplifying	O
fragment	O
I	O
,	O
and	O
Gal	B-GP
exFand	O
GalMtR	O
(	O
5	O
′-	O
GGC	O
AAT	O
CTT	O
GAA	O
GAG	O
GAT	O
GGT	O
CAC	O
TTC	O
AAA	O
-	O
3	O
′)	O
were	O
used	O
for	O
amplifying	O
fragment	O
II	O
.	O

After	O
the	O
two	O
fragments	O
were	O
amplified	O
,	O
the	O
full	O
length	O
of	O
MjGalΔ102	O
–	O
106	O
DNA	O
fragment	O
was	O
amplified	O
by	O
the	O
overlapping	O
PCR	O
using	O
the	O
two	O
purified	O
DNA	O
fragments	O
as	O
the	O
templates	O
.	O

And	O
it	O
was	O
ligated	O
to	O
Nde	B-GP
I	I-GP
and	O
Xho	B-GP
I	I-GP
site	O
of	O
expression	O
vector	O
[	O
pET30a	O
(+)].	O

Expression	O
and	O
purification	O
of	O
the	O
recombinant	O
mutant	O
MjGal	B-GP
were	O
performed	O
following	O
the	O
same	O
way	O
as	O
the	O
wild	O
type	O
MjGal	B-GP
.	O

Western	O
Blot	O
Analysis	O

Samples	O
were	O
run	O
on	O
12	O
.	O
5	O
%	O
SDS	O
-	O
PAGE	O
[	O
25	O
],	O
the	O
proteins	O
transferred	O
onto	O
a	O
nitrocellulose	O
membrane	O
,	O
blocked	O
with	O
3	O
%	O
nonfat	O
dry	O
milk	O
in	O
10	O
ml	O
TBS	O
(	O
10	O
mM	O
Tris	O
-	O
HCl	O
,	O
150	O
mM	O
NaCl	O
,	O
pH	O
8	O
.	O
0	O
)	O
for	O
1	O
h	O
at	O
RT	O
with	O
gentle	O
shaking	O
,	O
and	O
incubated	O
with	O
the	O
mouse	B-OG
anti	O
-	O
histidine	O
(	O
anti	O
-	O
His	O
)	O
antibody	B-GP
(	O
ZSGB	O
Bio	O
,	O
Beijing	O
,	O
China	O
,	O
1	O
∶	O
3000	O
dilution	O
in	O
block	O
reagent	O
)	O
for	O
at	O
least	O
4	O
h	O
at	O
RT	O
.	O

The	O
membrane	O
was	O
washed	O
with	O
TBST	O
(	O
0	O
.	O
1	O
%	O
Tween	O
-	O
20	O
in	O
TBS	O
)	O
3	O
times	O
for	O
10	O
min	O
each	O
,	O
and	O
incubated	O
with	O
alkaline	B-GP
phosphatase	I-GP
-	O
conjugated	O
horse	B-OG
anti	O
-	O
mouse	B-OG
IgG	B-GP
(	O
ZSGB	O
Bio	O
,	O
Beijing	O
,	O
China	O
,	O
1	O
∶	O
5000	O
dilution	O
in	O
block	O
reagent	O
)	O
for	O
at	O
least	O
3	O
h	O
.	O

This	O
was	O
followed	O
by	O
washing	O
for	O
3	O
×	O
10	O
min	O
with	O
TBST	O
and	O
1	O
×	O
10	O
min	O
with	O
TBS	O
,	O
and	O
signal	O
was	O
visualized	O
by	O
solution	O
[	O
45	O
µl	O
Nitroblue	O
Tetrazolium	O
(	O
75	O
mg	O
/	O
ml	O
),	O
and	O
35	O
µl	O
5	O
-	O
Bromo	O
-	O
4	O
-	O
chloro	O
-	O
3	O
-	O
Indolyl	O
Phosphate	O
(	O
50	O
mg	O
/	O
ml	O
)	O
in	O
10	O
ml	O
TBS	O
]	O
in	O
the	O
dark	O
.	O

Binding	O
Activity	O
of	O
rMjGal	B-GP
to	O
Bacteria	B-OG

Gram	O
-	O
positive	O
(	O
G	O
+)	O
bacteria	B-OG
(	O
B	B-OG
.	I-OG
megaterium	I-OG
,	O
B	B-OG
.	I-OG
subtilis	I-OG
,	O
B	B-OG
.	I-OG
thuringiensis	I-OG
and	O
S	B-OG
.	I-OG
aureus	I-OG
)	O
and	O
Gram	O
-	O
negative	O
(	O
G	O
−)	O
bacteria	B-OG
(	O
E	B-OG
.	I-OG
coli	I-OG
,	O
K	B-OG
.	I-OG
pneumoniae	I-OG
,	O
P	B-OG
.	I-OG
aeruginosa	I-OG
and	O
V	B-OG
.	I-OG
anguillarum	I-OG
)	O
were	O
tested	O
for	O
binding	O
by	O
MjGal	B-GP
following	O
the	O
method	O
previously	O
described	O
[	O
26	O
].	O

Bacteria	B-OG
cultured	O
in	O
LB	O
medium	O
(	O
1	O
%	O
Tryptone	O
,	O
1	O
%	O
NaCl	O
and	O
0	O
.	O
5	O
%	O
yeast	B-OG
extract	O
)	O
were	O
harvested	O
in	O
the	O
mid	O
-	O
logarithmic	O
phase	O
by	O
centrifugation	O
at	O
6	O
,	O
000	O
g	O
for	O
10	O
min	O
,	O
washed	O
twice	O
with	O
TBS	O
,	O
and	O
re	O
-	O
suspended	O
with	O
TBS	O
to	O
OD600	O
=	O
1	O
.	O
0	O
.	O

Purified	O
rMjGal	B-GP
(	O
500	O
µg	O
/	O
ml	O
,	O
6	O
µl	O
)	O
was	O
pre	O
-	O
incubated	O
with	O
either	O
lactose	O
(	O
200	O
mM	O
,	O
100	O
µl	O
),	O
glucose	O
(	O
200	O
mM	O
,	O
100	O
µl	O
),	O
LPS	O
or	O
LTA	O
(	O
1	O
µg	O
/	O
µl	O
,	O
50	O
µl	O
),	O
or	O
TBS	O
alone	O
for	O
1	O
h	O
,	O
and	O
suspensions	O
of	O
four	O
G	O
+	O
and	O
four	O
G	O
−	O
were	O
added	O
and	O
incubated	O
at	O
room	O
temperature	O
for	O
1	O
h	O
.	O

The	O
bacteria	B-OG
were	O
centrifuged	O
,	O
washed	O
four	O
times	O
with	O
TBS	O
,	O
and	O
treated	O
with	O
7	O
%	O
SDS	O
for	O
1	O
min	O
.	O

The	O
eluate	O
was	O
collected	O
by	O
centrifugation	O
at	O
10	O
,	O
000	O
g	O
,	O
subjected	O
to	O
SDS	O
-	O
PAGE	O
,	O
and	O
the	O
eluted	O
rMjGal	B-GP
detected	O
by	O
Western	O
blot	O
using	O
an	O
anti	O
-	O
His	O
antibody	B-GP
.	O

In	O
an	O
alternative	O
experimental	O
format	O
the	O
purified	O
recombinant	O
MjGal	B-GP
(	O
500	O
µg	O
/	O
ml	O
;	O
6	O
µl	O
)	O
was	O
added	O
to	O
the	O
bacterial	O
suspension	O
(	O
500	O
µl	O
;	O
2	O
×	O
107	O
cells	O
/	O
ml	O
)	O
and	O
incubated	O
for	O
30	O
min	O
at	O
RT	O
.	O

The	O
bacteria	B-OG
were	O
recovered	O
by	O
centrifugation	O
,	O
washed	O
four	O
times	O
with	O
TBS	O
as	O
described	O
above	O
,	O
and	O
either	O
lactose	O
(	O
200	O
mM	O
)	O
or	O
glucose	O
(	O
200	O
mM	O
;	O
negative	O
control	O
)	O
were	O
added	O
and	O
incubated	O
for	O
2	O
min	O
to	O
elute	O
the	O
bound	O
proteins	O
.	O

The	O
eluate	O
was	O
separated	O
by	O
centrifugation	O
at	O
10	O
,	O
000	O
g	O
.	O

Subsequently	O
,	O
a	O
second	O
elution	O
was	O
carried	O
out	O
with	O
7	O
%	O
SDS	O
for	O
1	O
min	O
,	O
and	O
the	O
eluate	O
separated	O
by	O
centrifugation	O
as	O
described	O
above	O
.	O

The	O
lactose	O
,	O
glucose	O
and	O
SDS	O
eluates	O
were	O
subjected	O
to	O
SDS	O
-	O
PAGE	O
,	O
and	O
the	O
eluted	O
MjGal	B-GP
detected	O
by	O
Western	O
blot	O
as	O
described	O
above	O
,	O
using	O
an	O
anti	O
-	O
His	O
antibody	B-GP
.	O

The	O
binding	O
activities	O
of	O
rMjGalΔ102	O
–	O
106	O
and	O
Trx	B-GP
-	O
His	O
to	O
bacteria	B-OG
were	O
examined	O
as	O
controls	O
,	O
using	O
the	O
same	O
protocol	O
.	O

Binding	O
of	O
MjGal	B-GP
and	O
MjGalΔ102	O
–	O
106	O
to	O
Bacterial	O
Glycans	O

The	O
binding	O
of	O
MjGal	B-GP
and	O
MjGalΔ102	O
–	O
106	O
to	O
bacterial	O
glycans	O
was	O
examined	O
by	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
following	O
a	O
protocol	O
reported	O
earlier	O
[	O
26	O
].	O

Briefly	O
,	O
each	O
well	O
of	O
the	O
microtiter	O
plate	O
(	O
Corning	O
,	O
USA	O
)	O
was	O
coated	O
with	O
2	O
µg	O
of	O
LPS	O
,	O
LTA	O
,	O
or	O
PGN	O
overnight	O
,	O
and	O
blocked	O
with	O
200	O
µl	O
of	O
BSA	B-GP
(	O
1	O
mg	O
/	O
ml	O
in	O
TBS	O
)	O
for	O
2	O
h	O
at	O
37	O
°	O
C	O
.	O

Fifty	O
microliters	O
of	O
purified	O
recombinant	O
MjGal	B-GP
or	O
MjGalΔ102	O
–	O
106	O
(	O
20	O
µg	O
/	O
ml	O
in	O
TBS	O
containing	O
0	O
.	O
1	O
mg	O
/	O
ml	O
BSA	B-GP
)	O
were	O
added	O
to	O
each	O
well	O
and	O
incubated	O
at	O
37	O
°	O
C	O
for	O
3	O
h	O
.	O

Controls	O
were	O
the	O
substitution	O
of	O
MjGal	B-GP
by	O
Trx	B-GP
-	O
His	O
.	O

After	O
washing	O
four	O
times	O
with	O
TBS	O
,	O
100	O
µl	O
of	O
mouse	B-OG
anti	O
-	O
histidine	O
(	O
anti	O
-	O
His	O
)	O
antibody	B-GP
(	O
1	O
∶	O
3000	O
diluted	O
by	O
TBS	O
containing	O
0	O
.	O
1	O
mg	O
/	O
ml	O
BSA	B-GP
)	O
were	O
added	O
to	O
each	O
well	O
and	O
incubated	O
at	O
37	O
°	O
C	O
for	O
1	O
h	O
.	O

The	O
wells	O
were	O
washed	O
four	O
times	O
as	O
described	O
above	O
,	O
and	O
the	O
phosphatase	B-GP
-	O
conjugated	O
horse	B-OG
anti	O
-	O
mouse	B-OG
IgG	B-GP
(	O
100	O
µl	O
of	O
1	O
/	O
1000	O
dilution	O
)	O
was	O
added	O
and	O
incubated	O
for	O
1	O
h	O
at	O
37	O
°	O
C	O
.	O

After	O
the	O
washing	O
four	O
times	O
with	O
TBS	O
,	O
the	O
plates	O
were	O
developed	O
by	O
100	O
µl	O
p	O
-	O
nitro	O
-	O
phenyl	O
phosphate	O
(	O
1	O
mg	O
/	O
ml	O
in	O
10	O
mM	O
diethanolamine	O
and	O
0	O
.	O
5	O
mM	O
MgCl2	O
).	O

Absorbance	O
at	O
405	O
nm	O
for	O
each	O
well	O
was	O
analyzed	O
by	O
a	O
plate	O
reader	O
(	O
Bio	O
-	O
Tek	O
instruments	O
).	O

The	O
assay	O
was	O
performed	O
in	O
triplicate	O
.	O

In	O
vivo	O
Clearance	O
of	O
MjGal	B-GP
-	O
coated	O
V	B-OG
.	I-OG
anguillarum	I-OG

The	O
in	O
vivo	O
bacterial	O
clearance	O
experiments	O
were	O
performed	O
following	O
methodology	O
reported	O
elsewhere	O
[	O
21	O
].	O

Briefly	O
,	O
V	B-OG
.	I-OG
anguillarum	I-OG
was	O
washed	O
twice	O
with	O
the	O
sterile	O
PBS	O
,	O
and	O
resuspended	O
to	O
the	O
final	O
concentration	O
of	O
8	O
×	O
108	O
cfu	O
/	O
ml	O
.	O

The	O
bacterial	O
suspension	O
(	O
500	O
µl	O
)	O
was	O
mixed	O
with	O
an	O
equal	O
volume	O
of	O
purified	O
rMjGal	B-GP
(	O
600	O
µg	O
/	O
ml	O
,	O
500	O
µl	O
)	O
and	O
incubated	O
at	O
28	O
°	O
C	O
for	O
30	O
min	O
with	O
gentle	O
mixing	O
.	O

Controls	O
consisted	O
in	O
the	O
substitution	O
of	O
rMjGal	B-GP
by	O
Trx	B-GP
-	O
His	O
,	O
and	O
PBS	O
alone	O
.	O

The	O
shrimp	B-OG
were	O
divided	O
into	O
three	O
groups	O
with	O
18	O
individuals	O
(∼	O
10	O
g	O
each	O
)	O
in	O
each	O
group	O
.	O

Fifty	O
µl	O
of	O
the	O
rMjGal	B-GP
-	O
coated	O
bacteria	B-OG
(	O
which	O
included	O
a	O
total	O
of	O
2	O
×	O
107	O
cfu	O
of	O
V	B-OG
.	I-OG
anguillarum	I-OG
together	O
with	O
15	O
µg	O
rMjGal	B-GP
)	O
or	O
controls	O
(	O
2	O
×	O
107	O
cfu	O
of	O
V	B-OG
.	I-OG
anguillarum	I-OG
together	O
with	O
15	O
µg	O
Trx	B-GP
-	O
His	O
,	O
or	O
PBS	O
alone	O
)	O
were	O
injected	O
into	O
the	O
third	O
abdominal	O
segment	O
of	O
each	O
shrimp	B-OG
from	O
experimental	O
or	O
control	O
groups	O
.	O

About	O
150	O
µl	O
of	O
hemolymph	O
of	O
each	O
shrimp	B-OG
were	O
collected	O
from	O
the	O
ventral	O
sinus	O
using	O
5	O
ml	O
sterile	O
syringe	O
preloaded	O
with	O
1	O
ml	O
ice	O
-	O
cold	O
anticoagulant	O
buffer	O
at	O
5	O
,	O
15	O
,	O
30	O
,	O
60	O
,	O
120	O
,	O
and	O
240	O
min	O
post	O
-	O
injection	O
.	O

The	O
hemolymph	O
samples	O
of	O
three	O
individual	O
shrimp	B-OG
from	O
each	O
group	O
were	O
immediately	O
pooled	O
,	O
serially	O
diluted	O
in	O
ice	O
-	O
cold	O
PBS	O
,	O
and	O
30	O
µl	O
of	O
each	O
dilution	O
plated	O
onto	O
2216E	O
agar	O
plates	O
(	O
0	O
.	O
1	O
%	O
yeast	B-OG
extract	O
,	O
0	O
.	O
5	O
%	O
tryptone	O
,	O
0	O
.	O
1	O
%	O
FeCl3	O
,	O
1	O
.	O
5	O
%	O
agar	O
,	O
and	O
2	O
.	O
4	O
%	O
artificial	O
seawater	O
salt	O
).	O

The	O
plates	O
were	O
incubated	O
overnight	O
at	O
37	O
°	O
C	O
,	O
and	O
the	O
number	O
of	O
bacterial	O
colonies	O
counted	O
for	O
each	O
of	O
the	O
three	O
experimental	O
and	O
control	O
groups	O
.	O

Binding	O
of	O
MjGal	B-GP
to	O
Shrimp	B-OG
Hemocytes	O
in	O
vitro	O

Binding	O
of	O
MjGal	B-GP
to	O
shrimp	B-OG
hemocytes	O
was	O
examined	O
in	O
vitro	O
by	O
adapting	O
a	O
cell	O
adhesion	O
assay	O
described	O
elsewhere	O
[	O
27	O
].	O

The	O
polylysine	O
pretreated	O
glass	O
slides	O
were	O
coated	O
with	O
purified	O
recombinant	O
rMjGal	B-GP
protein	O
(	O
10	O
µg	O
/	O
ml	O
,	O
200	O
µl	O
)	O
overnight	O
at	O
4	O
°	O
C	O
,	O
and	O
subsequently	O
blocked	O
with	O
BSA	B-GP
(	O
1	O
mg	O
/	O
ml	O
,	O
in	O
PBS	O
buffer	O
).	O

Slides	O
coated	O
with	O
Trx	B-GP
-	O
His	O
were	O
used	O
as	O
controls	O
.	O

Hemolymph	O
from	O
the	O
shrimp	B-OG
was	O
collected	O
from	O
the	O
ventral	O
sinus	O
using	O
5	O
ml	O
sterile	O
syringe	O
preloaded	O
with	O
ice	O
-	O
cold	O
anticoagulant	O
buffer	O
and	O
then	O
centrifuged	O
at	O
600	O
g	O
for	O
10	O
min	O
at	O
4	O
°	O
C	O
to	O
collect	O
the	O
hemocytes	O
.	O

After	O
adjusted	O
to	O
2	O
×	O
104	O
cell	O
/	O
ml	O
in	O
PBS	O
,	O
200	O
µl	O
of	O
the	O
hemocytes	O
suspension	O
was	O
added	O
into	O
the	O
slide	O
and	O
incubated	O
at	O
room	O
temperature	O
for	O
1	O
h	O
.	O

Then	O
the	O
unbound	O
hemocytes	O
were	O
washed	O
away	O
with	O
PBS	O
by	O
3	O
×	O
10	O
min	O
and	O
then	O
fixed	O
in	O
1	O
%	O
paraformaldehyde	O
.	O

Finally	O
,	O
the	O
number	O
of	O
attached	O
cells	O
was	O
counted	O
at	O
400	O
×	O
magnification	O
under	O
microscope	O
(	O
Olympus	O
BX51	O
,	O
Tokyo	O
,	O
Japan	O
).	O

In	O
the	O
control	O
groups	O
,	O
lactose	O
(	O
200	O
mM	O
)	O
was	O
added	O
onto	O
the	O
rMjGal	B-GP
-	O
coated	O
slide	O
at	O
room	O
temperature	O
for	O
1	O
h	O
before	O
the	O
hemocytes	O
were	O
added	O
.	O

Cell	O
adhesion	O
activity	O
was	O
calculated	O
in	O
comparison	O
with	O
the	O
numbers	O
of	O
fixed	O
hemocytes	O
between	O
rMjGal	B-GP
-	O
coated	O
slides	O
and	O
the	O
control	O
group	O
.	O

The	O
assays	O
were	O
performed	O
in	O
triplicate	O
.	O

Binding	O
of	O
MjGal	B-GP
to	O
Shrimp	B-OG
Hemocytes	O
in	O
vivo	O

The	O
binding	O
of	O
MjGal	B-GP
to	O
shrimp	B-OG
hemocytes	O
was	O
investigated	O
in	O
vivo	O
by	O
injecting	O
rMjGal	B-GP
into	O
shrimp	B-OG
(	O
50	O
µg	O
/	O
each	O
)	O
as	O
described	O
above	O
,	O
replacing	O
the	O
rMjGal	B-GP
with	O
Trx	B-GP
-	O
His	O
,	O
and	O
injecting	O
PBS	O
alone	O
as	O
the	O
controls	O
.	O

Hemolymph	O
was	O
collected	O
from	O
the	O
ventral	O
sinus	O
with	O
a	O
2	O
ml	O
sterile	O
syringe	O
preloaded	O
with	O
1	O
ml	O
anticoagulant	O
at	O
30	O
min	O
post	O
-	O
injection	O
,	O
and	O
the	O
hemocytes	O
were	O
isolated	O
by	O
centrifugation	O
at	O
600	O
g	O
for	O
10	O
min	O
at	O
4	O
°	O
C	O
.	O

After	O
washing	O
twice	O
with	O
PBS	O
,	O
the	O
hemocytes	O
were	O
fixed	O
with	O
1	O
%	O
paraformaldehyde	O
in	O
PBS	O
for	O
at	O
least	O
10	O
min	O
.	O

The	O
fixed	O
hemocytes	O
(	O
50	O
µl	O
)	O
were	O
placed	O
onto	O
a	O
glass	O
slide	O
pretreated	O
with	O
polylysine	O
and	O
allowed	O
to	O
settle	O
for	O
30	O
min	O
at	O
RT	O
.	O

After	O
blocking	O
with	O
3	O
%	O
BSA	B-GP
in	O
PBS	O
for	O
30	O
min	O
,	O
an	O
anti	O
-	O
His	O
mouse	B-OG
antibody	B-GP
(	O
1	O
/	O
1000	O
in	O
PBS	O
containing	O
3	O
%	O
BSA	B-GP
)	O
was	O
added	O
and	O
incubated	O
for	O
8	O
h	O
at	O
4	O
°	O
C	O
,	O
and	O
the	O
slides	O
washed	O
six	O
times	O
with	O
PBS	O
.	O

After	O
blocking	O
with	O
3	O
%	O
BSA	B-GP
in	O
PBS	O
for	O
5	O
min	O
,	O
FITC	O
-	O
conjugated	O
horse	B-OG
anti	O
-	O
mouse	B-OG
IgG	B-GP
(	O
1	O
∶	O
1000	O
in	O
PBS	O
containing	O
3	O
%	O
BSA	B-GP
)	O
was	O
added	O
to	O
the	O
glass	O
slide	O
and	O
incubated	O
for	O
1	O
h	O
at	O
37	O
°	O
C	O
in	O
the	O
dark	O
,	O
washed	O
six	O
times	O
with	O
PBS	O
for	O
10	O
min	O
each	O
,	O
stained	O
with	O
DAPI	O
(	O
1	O
/	O
1000	O
dilution	O
in	O
PBS	O
)	O
for	O
10	O
min	O
,	O
washed	O
again	O
six	O
times	O
with	O
PBS	O
for	O
10	O
min	O
each	O
,	O
and	O
examined	O
under	O
fluorescence	O
microscope	O
(	O
Olympus	O
BX51	O
,	O
Tokyo	O
,	O
Japan	O
).	O

Bacterial	O
Opsonization	O
and	O
Phagocytosis	O
in	O
vivo	O
Assay	O

This	O
assay	O
was	O
performed	O
following	O
a	O
previous	O
report	O
[	O
28	O
].	O

Briefly	O
,	O
V	B-OG
.	I-OG
anguillarum	I-OG
(	O
around	O
109	O
cfu	O
/	O
ml	O
)	O
were	O
heat	O
-	O
killed	O
(	O
75	O
°	O
C	O
for	O
30	O
min	O
),	O
washed	O
with	O
0	O
.	O
1	O
M	O
NaHCO3	O
(	O
pH	O
9	O
.	O
0	O
),	O
and	O
stained	O
with	O
fluorescein	O
isothiocyanate	O
(	O
FITC	O
)	O
(	O
Sigma	O
)	O
(	O
1	O
mg	O
/	O
ml	O
in	O
0	O
.	O
1	O
M	O
NaHCO3	O
)	O
at	O
25	O
°	O
C	O
for	O
1	O
h	O
,	O
with	O
gentle	O
shaking	O
.	O

The	O
labeled	O
bacteria	B-OG
were	O
washed	O
five	O
times	O
with	O
PBS	O
to	O
remove	O
any	O
remaining	O
FITC	O
,	O
resuspended	O
in	O
PBS	O
,	O
and	O
mixed	O
with	O
500	O
µg	O
rMjGal	B-GP
and	O
incubated	O
at	O
for	O
28	O
°	O
C	O
for	O
1	O
h	O
,	O
with	O
gentle	O
shaking	O
.	O

Finally	O
,	O
the	O
bacteria	B-OG
were	O
washed	O
three	O
times	O
with	O
PBS	O
and	O
adjusted	O
to	O
109	O
cells	O
/	O
ml	O
.	O

Trx	B-GP
-	O
His	O
replaced	O
the	O
rMjGal	B-GP
in	O
the	O
controls	O
.	O

Fifty	O
µl	O
of	O
the	O
labeled	O
bacteria	B-OG
coated	O
with	O
the	O
protein	O
were	O
injected	O
into	O
each	O
shrimp	B-OG
,	O
and	O
hemolymph	O
was	O
drawn	O
at	O
30	O
min	O
post	O
-	O
injection	O
,	O
and	O
as	O
described	O
above	O
the	O
hemocytes	O
collected	O
by	O
centrifugation	O
and	O
washed	O
twice	O
with	O
PBS	O
,	O
resuspended	O
in	O
paraformaldehyde	O
(	O
1	O
%	O
in	O
PBS	O
),	O
incubated	O
for	O
30	O
min	O
at	O
RT	O
,	O
and	O
washed	O
three	O
times	O
with	O
PBS	O
.	O

The	O
fixed	O
hemocytes	O
(	O
50	O
µl	O
)	O
were	O
placed	O
onto	O
a	O
glass	O
slide	O
pretreated	O
with	O
polylysine	O
and	O
allowed	O
to	O
settle	O
for	O
30	O
min	O
at	O
RT	O
.	O

Subsequently	O
,	O
trypan	O
blue	O
(	O
2	O
mg	O
/	O
ml	O
in	O
PBS	O
)	O
(	O
Amresco	O
)	O
were	O
added	O
to	O
quench	O
the	O
fluorescence	O
of	O
the	O
extracellular	O
(	O
non	O
-	O
phagocytosed	O
)	O
bacteria	B-OG
.	O

After	O
incubation	O
for	O
30	O
minutes	O
,	O
the	O
slide	O
was	O
gently	O
washed	O
five	O
times	O
with	O
PBS	O
,	O
and	O
observed	O
under	O
the	O
fluorescence	O
microscope	O
(	O
Olympus	O
BX51	O
,	O
Tokyo	O
,	O
Japan	O
).	O

Hemocytes	O
(	O
at	O
least	O
100	O
/	O
slide	O
)	O
were	O
counted	O
at	O
200	O
×	O
magnification	O
.	O

The	O
phagocytic	O
percentage	O
(	O
PP	O
)	O
was	O
calculated	O
as	O
follows	O
:	O
PP	O
=	O
(	O
number	O
of	O
cells	O
ingesting	O
bacteria	B-OG
/	O
number	O
of	O
cells	O
observed	O
)×	O
100	O
%.	O

The	O
assay	O
was	O
conducted	O
in	O
triplicate	O
.	O

The	O
data	O
statistically	O
analyzed	O
using	O
t	O
-	O
test	O
,	O
and	O
significant	O
differences	O
between	O
MjGal	B-GP
and	O
control	O
groups	O
were	O
accepted	O
at	O
P	O
<	O
0	O
.	O
05	O
.	O

Silencing	O
of	O
MjGal	B-GP
Expression	O
by	O
RNA	O
Interference	O
(	O
RNAi	O
)	O
and	O
Bacterial	O
Clearance	O
Assay	O

Preparation	O
of	O
DsRNA	O

Selected	O
stretches	O
(	O
546	O
bp	O
)	O
of	O
MjGal	B-GP
DNA	O
were	O
amplified	O
using	O
the	O
primers	O
:	O
RNAi	O
F	O
(	O
5	O
′-	O
TAA	O
TAC	O
GAC	O
TCA	O
CTA	O
TAG	O
G	O
TTT	O
CTC	O
CTG	O
GAC	O
GGA	O
TTG	O
CTC	O
AT	O
-	O
3	O
′)	O
and	O
RNAi	O
R	O
(	O
5	O
′-	O
TAA	O
TAC	O
GAC	O
TCA	O
CTA	O
TAG	O
G	O
CTG	O
CTT	O
GCT	O
GCT	O
GGT	O
AGG	O
GCT	O
GAT	O
T	O
-	O
3	O
′).	O

For	O
use	O
as	O
controls	O
,	O
the	O
primers	O
:	O
GFPi	O
F	O
(	O
5	O
′-	O
TAA	O
TAC	O
GAC	O
TCA	O
CTA	O
TAG	O
G	O
TGG	O
TCC	O
CAA	O
TTC	O
TCG	O
TGG	O
AAC	O
-	O
3	O
′)	O
and	O
GFPi	O
R	O
(	O
5	O
′-	O
TAA	O
TAC	O
GAC	O
TCA	O
CTA	O
TAG	O
G	O
CTT	O
GAA	O
GTT	O
GAC	O
CTT	O
GAT	O
GCC	O
-	O
3	O
′)	O
were	O
used	O
to	O
amplify	O
GFP	B-GP
DNA	O
.	O

The	O
sequences	O
underlined	O
correspond	O
to	O
the	O
T7	B-OG
promoter	O
.	O

The	O
amplification	O
products	O
were	O
extracted	O
and	O
precipitated	O
with	O
phenol	O
/	O
chloroform	O
and	O
ethanol	O
,	O
and	O
used	O
to	O
synthesize	O
dsRNA	O
.	O

The	O
transcription	O
was	O
performed	O
as	O
follows	O
:	O
6	O
µg	O
DNA	O
template	O
,	O
2	O
.	O
4	O
µl	O
10	O
mM	O
A	O
/	O
U	O
/	O
C	O
/	O
GTP	O
each	O
,	O
80	O
U	O
RioboLock	O
RNase	B-GP
Inhibiter	O
,	O
20	O
µl	O
5	O
×	O
transcription	O
buffer	O
and	O
80	O
U	O
T7	B-GP
RNA	I-GP
polymerase	I-GP
were	O
mixed	O
(	O
Fermentas	O
,	O
USA	O
).	O

Then	O
RNase	B-GP
-	O
free	O
water	O
was	O
added	O
to	O
a	O
total	O
volume	O
of	O
50	O
µl	O
,	O
and	O
incubated	O
overnight	O
at	O
37	O
°	O
C	O
.	O

To	O
remove	O
the	O
template	O
,	O
8	O
U	O
RNase	B-GP
-	O
free	O
DNase	B-GP
I	I-GP
,	O
10	O
µl	O
10	O
×	O
Reaction	O
Buffer	O
(	O
Fermentas	O
,	O
USA	O
),	O
32	O
µl	O
RNase	B-GP
-	O
free	O
water	O
were	O
added	O
and	O
incubated	O
at	O
37	O
°	O
C	O
for	O
30	O
min	O
.	O

After	O
extraction	O
and	O
precipitation	O
with	O
phenol	O
/	O
chloroform	O
and	O
ethanol	O
respectively	O
,	O
dsRNAs	O
were	O
dissolved	O
in	O
50	O
µl	O
RNase	B-GP
-	O
free	O
water	O
.	O

The	O
amount	O
and	O
purity	O
of	O
dsRNAs	O
were	O
analyzed	O
by	O
2	O
%	O
agarose	O
gel	O
electrophoresis	O
and	O
a	O
K5500	O
micro	O
-	O
spectrophotometer	O
(	O
Beijing	O
Kaiao	O
,	O
China	O
)	O
was	O
used	O
to	O
quantify	O
the	O
amount	O
of	O
dsRNAs	O
.	O

RNAi	O
assay	O

Shrimp	B-OG
(∼	O
10	O
g	O
)	O
were	O
divided	O
into	O
two	O
groups	O
,	O
and	O
injected	O
with	O
either	O
40	O
µg	O
MjGal	B-GP
dsRNAs	O
or	O
GFP	B-GP
dsRNAs	O
(	O
controls	O
).	O

A	O
similar	O
second	O
injection	O
of	O
dsRNA	O
was	O
performed	O
24	O
h	O
later	O
.	O

Before	O
conducting	O
the	O
clearance	O
assay	O
,	O
three	O
shrimp	B-OG
of	O
each	O
group	O
were	O
selected	O
and	O
the	O
RNA	O
of	O
the	O
hemocytes	O
and	O
gills	O
were	O
isolated	O
to	O
synthesize	O
cDNA	O
and	O
confirm	O
silencing	O
of	O
MjGal	B-GP
expression	O
.	O

A	O
pair	O
of	O
primers	O
:	O
Check	O
F	O
(	O
5	O
′-	O
TTT	O
CTC	O
CTG	O
GAC	O
GGA	O
TTG	O
CT	O
-	O
3	O
′)	O
and	O
Check	O
R	O
(	O
5	O
′-	O
CCT	O
GCT	O
GCC	O
ATC	O
CCC	O
AGT	O
AAT	O
C	O
-	O
3	O
′)	O
were	O
used	O
for	O
RT	O
-	O
PCR	O
amplification	O
.	O

Bacterial	O
clearance	O
assay	O

V	B-OG
.	I-OG
anguillarum	I-OG
(	O
2	O
×	O
107	O
cells	O
)	O
were	O
injected	O
into	O
shrimp	B-OG
12	O
h	O
after	O
the	O
dsRNA	O
second	O
injection	O
.	O

At	O
5	O
,	O
15	O
,	O
60	O
min	O
of	O
post	O
-	O
infection	B-DS
,	O
hemolymph	O
was	O
collected	O
from	O
the	O
two	O
groups	O
,	O
and	O
serially	O
diluted	O
immediately	O
.	O

Fifty	O
µl	O
of	O
each	O
dilution	O
were	O
plated	O
onto	O
2216E	O
agar	O
plates	O
,	O
incubated	O
at	O
37	O
°	O
C	O
overnight	O
,	O
and	O
the	O
colonies	O
counted	O
as	O
described	O
above	O
.	O

Results	O

CDNA	O
Cloning	O
and	O
Phylogenetic	O
Analysis	O
of	O
MjGal	B-GP

The	O
full	O
length	O
of	O
MjGal	B-GP
was	O
obtained	O
by	O
random	O
sequencing	O
(	O
GenBank	O
accession	O
No	O
.	O
JQ804931	O
).	O

It	O
contained	O
an	O
open	O
reading	O
frame	O
(	O
ORF	O
)	O
of	O
1002	O
bp	O
encoding	O
a	O
protein	O
of	O
333	O
amino	O
acids	O
,	O
and	O
contained	O
a	O
galactoside	O
-	O
binding	O
lectin	B-GP
domain	O
.	O

The	O
theoretical	O
pI	O
and	O
molecular	O
mass	O
of	O
mature	O
MjGal	B-GP
was	O
7	O
.	O
7	O
and	O
33	O
.	O
5	O
kDa	O
,	O
respectively	O
.	O

BLAST	O
analysis	O
showed	O
that	O
MjGal	B-GP
shares	O
high	O
identity	O
with	O
galectins	B-GP
from	O
crustaceans	B-OG
such	O
as	O
the	O
Pacific	B-OG
white	I-OG
shrimp	I-OG
,	O
Litopenaeus	B-OG
vannamei	I-OG
(	O
AGV04659	O
,	O
89	O
%)	O
and	O
the	O
Chinese	B-OG
mitten	I-OG
crab	I-OG
Eriocheir	B-OG
sinensis	I-OG
(	O
ADF32023	O
,	O
58	O
%),	O
but	O
to	O
a	O
lesser	O
degree	O
to	O
the	O
galectin	B-GP
from	O
the	O
water	B-OG
flea	I-OG
Daphnia	B-OG
pulex	I-OG
(	O
EFX86664	O
.	O
1	O
,	O
28	O
%).	O
MjGal	B-GP
also	O
showed	O
similarity	O
to	O
galectins	B-GP
from	O
insects	B-OG
,	O
such	O
as	O
those	O
from	O
the	O
leaf	B-OG
-	I-OG
cutter	I-OG
ant	I-OG
Acromyrmex	B-OG
echinatior	I-OG
(	O
EGI70288	O
.	O
1	O
,	O
34	O
%),	O
the	O
honeybee	B-OG
Apis	B-OG
florea	I-OG
(	O
XP_003696651	O
.	O
1	O
,	O
36	O
%),	O
the	O
jumping	B-OG
ant	I-OG
Harpegnathos	B-OG
saltator	I-OG
(	O
EFN89847	O
.	O
1	O
,	O
34	O
%),	O
and	O
the	O
bumble	B-OG
bee	I-OG
Bombus	B-OG
impatiens	I-OG
(	O
XP_003493369	O
.	O
1	O
,	O
33	O
%).	O

The	O
MjGal	B-GP
sequence	O
displayed	O
similarity	O
with	O
some	O
mollusk	B-OG
galectins	B-GP
,	O
such	O
as	O
those	O
from	O
the	O
European	B-OG
oyster	I-OG
Ostrea	B-OG
edulis	I-OG
(	O
ADF80416	O
.	O
1	O
,	O
34	O
%),	O
the	O
clam	B-OG
Ruditapes	B-OG
philippinarum	I-OG
(	O
ACA09732	O
.	O
1	O
,	O
34	O
%)	O
and	O
the	O
Pacific	B-OG
oyster	I-OG
Crassostrea	B-OG
gigas	I-OG
(	O
EKC40502	O
.	O
1	O
,	O
28	O
%).	O

A	O
phylogenetic	O
tree	O
(	O
MEGA	O
5	O
.	O
05	O
software	O
)	O
based	O
on	O
the	O
amino	O
acid	O
sequences	O
of	O
selected	O
galectins	B-GP
(	O
Fig	O
.	O
1	O
)	O
revealed	O
that	O
MjGal	B-GP
clustered	O
with	O
galectins	B-GP
from	O
arthropods	B-OG
and	O
the	O
hemichordate	B-OG
Saccoglossus	B-OG
kowalevskii	I-OG
,	O
whereas	O
all	O
galectins	B-GP
from	O
vertebrates	B-OG
formed	O
a	O
separate	O
cluster	O
.	O

Phylogenetic	O
analysis	O
of	O
MjGal	B-GP
.	O

The	O
tree	O
was	O
constructed	O
with	O
the	O
MEGA	O
5	O
.	O
05	O
software	O
.	O

One	O
thousand	O
bootstraps	O
were	O
used	O
to	O
check	O
the	O
repeatability	O
of	O
the	O
results	O
.	O

The	O
galectin	B-GP
sequences	O
of	O
selected	O
invertebrate	B-OG
and	O
vertebrate	B-OG
species	O
were	O
obtained	O
from	O
NCBI	O
GenBank	O
.	O
MjGal	B-GP
is	O
labeled	O
with	O
a	O
solid	O
triangle	O
.	O

MjGal	B-GP
was	O
Up	O
-	O
regulated	O
by	O
V	B-OG
.	I-OG
anguillarum	I-OG
Challenge	O

Expression	O
of	O
MjGal	B-GP
mRNA	O
in	O
various	O
tissues	O
was	O
examined	O
by	O
RT	O
-	O
PCR	O
.	O
MjGal	B-GP
was	O
detected	O
in	O
all	O
the	O
tested	O
tissues	O
including	O
hemocytes	O
,	O
heart	O
,	O
hepatopancreas	O
,	O
gills	O
and	O
intestine	O
with	O
a	O
high	O
level	O
,	O
and	O
at	O
a	O
relatively	O
lower	O
level	O
,	O
in	O
the	O
stomach	O
(	O
Fig	O
.	O
2A	O
).	O

A	O
time	O
-	O
course	O
assessment	O
of	O
MjGal	B-GP
expression	O
upon	O
V	B-OG
.	I-OG
anguillarum	I-OG
challenge	O
showed	O
that	O
MjGal	B-GP
expression	O
was	O
up	O
-	O
regulated	O
about	O
4	O
-	O
fold	O
both	O
in	O
the	O
hemocytes	O
(	O
Fig	O
.	O
2B	O
)	O
and	O
hepatopancreas	O
(	O
Fig	O
.	O
2C	O
)	O
over	O
the	O
PBS	O
-	O
control	O
at	O
12	O
h	O
post	O
-	O
injection	O
,	O
and	O
these	O
were	O
recovered	O
at	O
48	O
h	O
post	O
-	O
injection	O
(	O
Fig	O
.	O
2B	O
and	O
C	O
).	O

Temporal	O
and	O
spatial	O
expression	O
of	O
MjGal	B-GP
.	O

Total	O
RNAs	O
from	O
different	O
tissues	O
of	O
unchallenged	O
and	O
V	B-OG
.	I-OG
anguillarum	I-OG
or	O
PBS	O
challenged	O
shrimp	B-OG
were	O
reverse	O
transcribed	O
to	O
cDNAs	O
that	O
served	O
as	O
templates	O
for	O
PCR	O
amplification	O
.	O

(	O
A	O
)	O
Expression	O
of	O
MjGal	B-GP
in	O
different	O
tissues	O
of	O
naïve	O
animals	B-OG
as	O
assessed	O
by	O
RT	O
-	O
PCR	O
.	O

The	O
time	O
-	O
course	O
expression	O
of	O
MjGal	B-GP
was	O
upon	O
V	B-OG
.	I-OG
anguillarum	I-OG
challenge	O
was	O
analyzed	O
by	O
qRT	O
-	O
PCR	O
in	O
hemocytes	O
(	O
B	O
)	O
and	O
hepatopancreas	O
(	O
C	O
),	O
with	O
β	B-GP
-	I-GP
actin	I-GP
serving	O
as	O
the	O
reference	O
gene	O
.	O

The	O
histograms	O
show	O
the	O
statistical	O
analysis	O
of	O
the	O
quantitative	O
real	O
-	O
time	O
PCR	O
results	O
.	O

The	O
asterisks	O
indicate	O
significant	O
differences	O
(**	O
P	O
<	O
0	O
.	O
01	O
,	O
***	O
P	O
<	O
0	O
.	O
001	O
)	O
between	O
the	O
V	B-OG
.	I-OG
anguillarum	I-OG
-	O
challenged	O
and	O
PBS	O
-	O
injected	O
group	O
.	O

Error	O
bars	O
represent	O
±	O
SD	O
of	O
three	O
independent	O
PCR	O
amplifications	O
and	O
quantifications	O
.	O

Recombinant	O
MjGal	B-GP
Bound	O
to	O
but	O
did	O
not	O
Agglutinate	O
Bacteria	B-OG

MjGal	B-GP
and	O
MjGalΔ102	O
–	O
106	O
were	O
recombinant	O
expressed	O
in	O
E	B-OG
.	I-OG
coli	I-OG
BL21	I-OG
(	O
DE3	O
)	O
and	O
purified	O
by	O
His	O
Bind	O
resin	O
chromatography	O
.	O

The	O
molecular	O
mass	O
of	O
the	O
recombinant	O
MjGal	B-GP
and	O
MjGalΔ102	O
–	O
106	O
were	O
consistent	O
to	O
the	O
expected	O
molecular	O
mass	O
(	O
Fig	O
.	O
3A	O
and	O
B	O
).	O

Expression	O
of	O
recombinant	O
MjGal	B-GP
(	O
rMjGal	B-GP
),	O
rMjGalΔ102	O
–	O
106	O
and	O
their	O
bacteria	B-OG
binding	O
assay	O
by	O
Western	O
blot	O
.	O

(	O
A	O
)	O
Lane	O
1	O
,	O
purified	O
rMjGal	B-GP
;	O
lane	O
2	O
,	O
purified	O
rMjGalΔ102	O
–	O
106	O
;	O
lane	O
3	O
,	O
purified	O
Trx	B-GP
-	O
His	O
which	O
was	O
used	O
as	O
the	O
control	O
;	O
lane	O
4	O
,	O
protein	O
markers	O
.	O

(	O
B	O
)	O
Schematic	O
diagram	O
of	O
the	O
five	O
deleted	O
residues	O
(	O
Cys102	O
-	O
Cys106	O
)	O
in	O
mutant	O
MjGalΔ102	O
–	O
106	O
.	O

(	O
C	O
)	O
Purified	O
rMjGal	B-GP
(	O
500	O
µg	O
/	O
ml	O
)	O
was	O
pre	O
-	O
incubated	O
with	O
either	O
lactose	O
(	O
200	O
mM	O
),	O
glucose	O
(	O
200	O
mM	O
),	O
or	O
TBS	O
alone	O
for	O
1	O
h	O
,	O
and	O
suspensions	O
of	O
four	O
Gram	O
-	O
positive	O
(	O
G	O
+)	O
bacteria	B-OG
(	O
S	B-OG
.	I-OG
aureus	I-OG
,	O
B	B-OG
.	I-OG
subtilis	I-OG
,	O
B	B-OG
.	I-OG
megaterium	I-OG
and	O
B	B-OG
.	I-OG
thuringiensis	I-OG
)	O
and	O
four	O
Gram	O
-	O
negative	O
(	O
G	O
−)	O
bacteria	B-OG
(	O
V	B-OG
.	I-OG
anguillarum	I-OG
,	O
K	B-OG
.	I-OG
pneumoniae	I-OG
,	O
E	B-OG
.	I-OG
coli	I-OG
and	O
P	B-OG
.	I-OG
aeruginosa	I-OG
)	O
were	O
added	O
and	O
incubated	O
at	O
room	O
temperature	O
for	O
1	O
h	O
.	O

The	O
bacteria	B-OG
were	O
centrifuged	O
,	O
washed	O
four	O
times	O
with	O
TBS	O
,	O
and	O
treated	O
with	O
7	O
%	O
SDS	O
for	O
1	O
min	O
.	O

The	O
eluate	O
was	O
collected	O
by	O
centrifugation	O
,	O
subjected	O
to	O
SDS	O
-	O
PAGE	O
,	O
and	O
the	O
eluted	O
rMjGal	B-GP
detected	O
by	O
Western	O
blot	O
using	O
anti	O
-	O
His	O
antibody	B-GP
.	O

(	O
D	O
)	O
The	O
purified	O
rMjGal	B-GP
was	O
pre	O
-	O
incubated	O
with	O
excess	O
LPS	O
or	O
LTA	O
before	O
the	O
bacteria	B-OG
were	O
added	O
,	O
and	O
the	O
binding	O
activity	O
for	O
bacteria	B-OG
was	O
tested	O
by	O
western	O
blot	O
.	O

(	O
E	O
)	O
Purified	O
rMjGalΔ102	O
–	O
106	O
or	O
Trx	B-GP
-	O
His	O
were	O
also	O
used	O
as	O
controls	O
for	O
the	O
bacteria	B-OG
binding	O
activity	O
.	O

Recombinant	O
MjGal	B-GP
bound	O
to	O
the	O
various	O
microorganisms	O
tested	O
,	O
including	O
four	O
G	O
+	O
bacteria	B-OG
(	O
S	B-OG
.	I-OG
aureus	I-OG
,	O
B	B-OG
.	I-OG
thuringiensis	I-OG
,	O
B	B-OG
.	I-OG
subtilis	I-OG
and	O
B	B-OG
.	I-OG
megaterium	I-OG
)	O
and	O
four	O
G	O
−	O
bacteria	B-OG
(	O
E	B-OG
.	I-OG
coli	I-OG
,	O
V	B-OG
.	I-OG
anguillarum	I-OG
,	O
K	B-OG
.	I-OG
pneumoniae	I-OG
and	O
P	B-OG
.	I-OG
aeruginosa	I-OG
).	O

The	O
results	O
showed	O
that	O
MjGal	B-GP
strongly	O
bound	O
to	O
different	O
bacteria	B-OG
,	O
especially	O
the	O
G	O
−	O
bacteria	B-OG
.	O

To	O
test	O
whether	O
pre	O
-	O
exposure	O
of	O
rMjGal	B-GP
to	O
a	O
galectin	B-GP
carbohydrate	O
ligand	O
could	O
prevent	O
the	O
binding	O
of	O
rMjGal	B-GP
to	O
the	O
bacteria	B-OG
,	O
the	O
purified	O
rMjGal	B-GP
(	O
500	O
µg	O
/	O
ml	O
)	O
was	O
pre	O
-	O
incubated	O
with	O
lactose	O
(	O
a	O
typical	O
galectin	B-GP
ligand	O
)	O
or	O
glucose	O
(	O
as	O
the	O
negative	O
control	O
),	O
and	O
the	O
bacteria	B-OG
were	O
added	O
,	O
incubated	O
for	O
1	O
h	O
,	O
washed	O
,	O
and	O
the	O
bound	O
proteins	O
eluted	O
with	O
7	O
%	O
SDS	O
.	O

As	O
shown	O
in	O
Fig	O
.	O
3C	O
,	O
the	O
pre	O
-	O
incubation	O
with	O
either	O
lactose	O
or	O
glucose	O
had	O
no	O
effect	O
on	O
the	O
binding	O
of	O
rMjGal	B-GP
to	O
the	O
selected	O
bacteria	B-OG
.	O

An	O
alternative	O
experimental	O
format	O
was	O
tested	O
to	O
examine	O
whether	O
lactose	O
could	O
displace	O
the	O
rMjGal	B-GP
bound	O
to	O
bacteria	B-OG
.	O

For	O
this	O
,	O
the	O
G	O
+	O
and	O
G	O
−	O
bacteria	B-OG
were	O
incubated	O
with	O
the	O
purified	O
rMjGal	B-GP
(	O
500	O
µg	O
/	O
ml	O
)	O
for	O
1	O
h	O
,	O
washed	O
and	O
eluted	O
with	O
either	O
200	O
mM	O
lactose	O
or	O
glucose	O
.	O

The	O
sugar	O
failed	O
to	O
displace	O
any	O
bound	O
rMjGal	B-GP
,	O
but	O
the	O
protein	O
could	O
be	O
readily	O
eluted	O
from	O
the	O
bacteria	B-OG
with	O
7	O
%	O
SDS	O
(	O
Data	O
not	O
shown	O
).	O

Pre	O
-	O
incubation	O
of	O
rMjGal	B-GP
with	O
LPS	O
and	O
LTA	O
showed	O
that	O
LPS	O
partially	O
inhibited	O
the	O
binding	O
activity	O
of	O
rMjGal	B-GP
to	O
bacteria	B-OG
,	O
whereas	O
LTA	O
completely	O
inhibited	O
the	O
binding	O
activity	O
(	O
Fig	O
.	O
3D	O
).	O

The	O
binding	O
activity	O
of	O
rMjGalΔ102	O
–	O
106	O
for	O
bacteria	B-OG
was	O
much	O
weaker	O
than	O
that	O
of	O
the	O
wild	O
type	O
rMjGal	B-GP
(	O
Fig	O
.	O
3E	O
).	O

Trx	B-GP
-	O
His	O
did	O
not	O
show	O
binding	O
activity	O
for	O
bacteria	B-OG
(	O
Fig	O
.	O
3E	O
).	O

Taken	O
together	O
,	O
the	O
results	O
showed	O
that	O
rMjGal	B-GP
bound	O
strongly	O
to	O
the	O
selected	O
bacterial	O
species	O
tested	O
,	O
that	O
the	O
binding	O
takes	O
place	O
via	O
the	O
CRD	O
,	O
and	O
that	O
although	O
lactose	O
could	O
not	O
inhibit	O
or	O
displace	O
the	O
binding	O
of	O
the	O
galectin	B-GP
to	O
bacteria	B-OG
,	O
both	O
LTA	O
and	O
LPS	O
could	O
function	O
as	O
effective	O
binding	O
inhibitors	O
.	O

It	O
is	O
noteworthy	O
that	O
an	O
agglutination	O
assay	O
with	O
rMjGal	B-GP
and	O
the	O
bacterial	O
species	O
described	O
above	O
showed	O
no	O
agglutination	O
for	O
any	O
of	O
the	O
bacteria	B-OG
tested	O
(	O
Data	O
not	O
shown	O
).	O

rMjGal	B-GP
Bound	O
to	O
LPS	O
and	O
LTA	O
Strongly	O
and	O
rMjGalΔ102	O
–	O
106	O
Bound	O
to	O
LPS	O
and	O
LTA	O
Weakly	O

The	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
was	O
performed	O
to	O
detect	O
whether	O
rMjGal	B-GP
bound	O
to	O
polysaccharides	O
(	O
LPS	O
,	O
PGN	O
and	O
LTA	O
).	O

The	O
results	O
showed	O
that	O
rMjGal	B-GP
could	O
bind	O
to	O
polysaccharides	O
,	O
including	O
LPS	O
and	O
LTA	O
,	O
but	O
not	O
PGN	O
(	O
data	O
not	O
shown	O
).	O

The	O
binding	O
of	O
MjGal	B-GP
to	O
polysaccharides	O
was	O
saturable	O
(	O
Fig	O
.	O
4A	O
and	O
4B	O
).	O

In	O
ELISA	O
,	O
the	O
rMjGalΔ102	O
–	O
106	O
showed	O
a	O
relatively	O
weaker	O
binding	O
activity	O
to	O
LPS	O
and	O
LTA	O
compared	O
to	O
the	O
wild	O
type	O
rMjGal	B-GP
.	O

rMjGal	B-GP
strongly	O
bound	O
to	O
lipopolysaccharide	O
(	O
LPS	O
),	O
lipoteichoic	O
acid	O
(	O
LTA	O
).	O

rMjGalΔ102	O
–	O
106	O
weakly	O
bound	O
to	O
LPS	O
,	O
LTA	O
.	O

Three	O
polysaccharides	O
LPS	O
,	O
LTA	O
and	O
peptidoglycan	O
(	O
PGN	O
)	O
were	O
used	O
in	O
this	O
binding	O
assay	O
.	O

Microtiter	O
plates	O
were	O
coated	O
with	O
2	O
µg	O
of	O
LPS	O
(	O
A	O
)	O
or	O
LTA	O
(	O
B	O
),	O
and	O
incubated	O
with	O
increasing	O
concentrations	O
of	O
rMjGal	B-GP
or	O
rMjGalΔ102	O
–	O
106	O
(	O
0	O
,	O
1	O
,	O
2	O
,	O
5	O
,	O
10	O
,	O
20	O
µg	O
/	O
ml	O
).	O

Binding	O
of	O
rMjGal	B-GP
or	O
rMjGalΔ102	O
–	O
106	O
was	O
detected	O
using	O
anti	O
-	O
Histidine	O
antibody	B-GP
.	O

Data	O
shown	O
are	O
the	O
mean	O
±	O
SEM	O
derived	O
from	O
three	O
repeats	O
.	O

No	O
binding	O
to	O
PGN	O
could	O
be	O
detected	O
at	O
any	O
of	O
the	O
rMjGal	B-GP
concentrations	O
tested	O
(	O
results	O
not	O
shown	O
).	O

rMjGal	B-GP
Enhanced	O
the	O
Bacterial	O
Clearance	O
Activity	O
in	O
vivo	O

To	O
investigate	O
the	O
clearance	O
activity	O
of	O
rMjGal	B-GP
,	O
the	O
shrimp	B-OG
were	O
injected	O
with	O
V	B-OG
.	I-OG
anguillarum	I-OG
that	O
had	O
been	O
pre	O
-	O
incubated	O
with	O
either	O
rMjGal	B-GP
,	O
Trx	B-GP
-	O
His	O
,	O
or	O
PBS	O
,	O
and	O
the	O
bacteria	B-OG
remaining	O
in	O
the	O
hemolymph	O
were	O
counted	O
at	O
different	O
time	O
points	O
after	O
injection	O
.	O

The	O
bacterial	O
counts	O
in	O
the	O
rMjGal	B-GP
-	O
coated	O
group	O
were	O
significantly	O
lower	O
as	O
compared	O
with	O
two	O
control	O
groups	O
.	O

Further	O
,	O
the	O
two	O
control	O
groups	O
took	O
significantly	O
longer	O
time	O
to	O
reach	O
the	O
similar	O
clearance	O
level	O
of	O
the	O
experimental	O
group	O
(	O
Fig	O
.	O
5	O
).	O

The	O
results	O
suggested	O
that	O
rMjGal	B-GP
could	O
enhance	O
the	O
clearance	O
activity	O
of	O
V	B-OG
.	I-OG
anguillarum	I-OG
in	O
vivo	O
.	O

The	O
activity	O
of	O
rMjGal	B-GP
in	O
the	O
clearance	O
of	O
V	B-OG
.	I-OG
anguillarum	I-OG
.	O

Bacteria	B-OG
(	O
2	O
×	O
107	O
cells	O
)	O
pre	O
-	O
incubated	O
with	O
rMjGal	B-GP
(	O
15	O
µg	O
)	O
were	O
injected	O
into	O
the	O
shrimp	B-OG
.	O

Hemolymph	O
was	O
collected	O
,	O
diluted	O
1	O
∶	O
1000	O
,	O
and	O
plated	O
on	O
2216E	O
agar	O
plates	O
.	O

Bacterial	O
colonies	O
were	O
counted	O
after	O
37	O
°	O
C	O
cultivation	O
for	O
12	O
h	O
.	O

Results	O
represent	O
as	O
the	O
number	O
of	O
bacteria	B-OG
from	O
three	O
independent	O
repeats	O
and	O
expressed	O
as	O
mean	O
values	O
±	O
S	O
.	O
D	O
.	O

Asterisks	O
indicate	O
significant	O
differences	O
(*	O
P	O
<	O
0	O
.	O
05	O
,	O
**	O
P	O
<	O
0	O
.	O
01	O
,	O
***	O
P	O
<	O
0	O
.	O
001	O
).	O

rMjGal	B-GP
Bound	O
to	O
the	O
Shrimp	B-OG
Hemocyte	O
Surface	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O

To	O
examine	O
the	O
possible	O
mechanism	O
responsible	O
for	O
the	O
above	O
observation	O
,	O
the	O
binding	O
of	O
rMjGal	B-GP
to	O
shrimp	B-OG
hemocytes	O
was	O
assessed	O
in	O
vitro	O
by	O
a	O
standard	O
cell	O
adhesion	O
assay	O
in	O
glass	O
slides	O
that	O
had	O
been	O
pre	O
-	O
coated	O
with	O
rMjGal	B-GP
or	O
control	O
protein	O
.	O

The	O
results	O
revealed	O
that	O
a	O
significantly	O
higher	O
number	O
of	O
hemocytes	O
adhered	O
to	O
the	O
rMjGal	B-GP
-	O
coated	O
slide	O
than	O
to	O
the	O
Trx	B-GP
-	O
His	O
-	O
coated	O
slide	O
.	O

The	O
addition	O
of	O
lactose	O
reduced	O
significantly	O
the	O
number	O
of	O
hemocytes	O
that	O
adhered	O
to	O
the	O
rMjGal	B-GP
-	O
coated	O
slide	O
as	O
compared	O
to	O
the	O
control	O
group	O
(	O
Fig	O
.	O
6A	O
and	O
6B	O
).	O

A	O
reduction	O
in	O
hemocyte	O
adhesion	O
in	O
the	O
Trx	B-GP
-	O
His	O
-	O
coated	O
slide	O
by	O
addition	O
of	O
lactose	O
was	O
possibly	O
due	O
to	O
inhibition	O
of	O
the	O
hemocyte	O
endogenous	O
galectin	B-GP
secreted	O
and	O
bound	O
to	O
the	O
surface	O
of	O
the	O
hemocytes	O
that	O
might	O
partially	O
contribute	O
to	O
hemocyte	O
binding	O
to	O
the	O
slide	O
.	O

In	O
vitro	O
binding	O
of	O
rMjGal	B-GP
to	O
shrimp	B-OG
hemocytes	O
.	O

(	O
A	O
)	O
Shrimp	B-OG
hemocytes	O
(	O
2	O
×	O
104	O
cells	O
/	O
ml	O
)	O
were	O
added	O
to	O
the	O
slide	O
glass	O
pre	O
-	O
coated	O
with	O
rMjGal	B-GP
,	O
rMjGal	B-GP
with	O
lactose	O
,	O
Trx	B-GP
-	O
His	O
,	O
or	O
Trx	B-GP
-	O
His	O
with	O
lactose	O
.	O

One	O
hour	O
later	O
,	O
the	O
slide	O
was	O
washed	O
three	O
times	O
with	O
PBS	O
and	O
observed	O
under	O
the	O
microscope	O
.	O

The	O
number	O
of	O
hemocytes	O
counted	O
at	O
400	O
×	O
magnification	O
under	O
microscope	O
.	O

Figures	O
showed	O
the	O
hemocytes	O
which	O
were	O
adhered	O
to	O
the	O
slides	O
after	O
the	O
washing	O
.	O

Assays	O
were	O
performed	O
in	O
triplicate	O
with	O
three	O
different	O
hemocytes	O
suspensions	O
from	O
each	O
shrimp	B-OG
.	O

Bar	O
=	O
100	O
µm	O
.	O

(	O
B	O
)	O
Statistical	O
analysis	O
of	O
the	O
data	O
from	O
(	O
A	O
)	O
using	O
GraghPad	O
software	O
.	O

Significant	O
differences	O
were	O
analyzed	O
by	O
one	O
way	O
ANOVA	O
by	O
a	O
Trukey	O
’	O
s	O
multiple	O
comparison	O
test	O
and	O
indicated	O
by	O
asterisks	O
(**	O
P	O
<	O
0	O
.	O
01	O
,	O
***	O
P	O
<	O
0	O
.	O
001	O
).	O

The	O
bar	O
was	O
100	O
µm	O
.	O

To	O
verify	O
if	O
the	O
in	O
vitro	O
rMjGal	B-GP
-	O
shrimp	B-OG
hemocyte	O
interactions	O
above	O
also	O
occurred	O
in	O
vivo	O
,	O
shrimp	B-OG
were	O
injected	O
with	O
rMjGal	B-GP
,	O
and	O
after	O
30	O
min	O
the	O
hemocytes	O
collected	O
as	O
described	O
above	O
,	O
and	O
the	O
presence	O
of	O
surface	O
-	O
bound	O
rMjGal	B-GP
examined	O
by	O
immunocytochemistry	O
.	O

The	O
images	O
in	O
Fig	O
.	O
7	O
show	O
the	O
green	O
signal	O
on	O
the	O
edge	O
of	O
the	O
hemocytes	O
collected	O
from	O
shrimp	B-OG
injected	O
with	O
rMjGal	B-GP
,	O
and	O
a	O
significantly	O
weaker	O
signal	O
in	O
the	O
control	O
group	O
.	O

These	O
results	O
indicated	O
that	O
the	O
rMjGal	B-GP
can	O
bind	O
to	O
the	O
hemocyte	O
surface	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

In	O
vivo	O
binding	O
of	O
rMjGal	B-GP
to	O
shrimp	B-OG
hemocytes	O
.	O

rMjGal	B-GP
,	O
Trx	B-GP
-	O
His	O
,	O
or	O
PBS	O
were	O
injected	O
into	O
shrimp	B-OG
and	O
the	O
hemocytes	O
were	O
collected	O
and	O
analyzed	O
by	O
immunohistochemistry	O
.	O

The	O
left	O
panel	O
indicated	O
the	O
binding	O
signal	O
detected	O
by	O
the	O
anti	O
-	O
Histidine	O
antibody	B-GP
for	O
the	O
recombinant	O
protein	O
(	O
Green	O
),	O
the	O
middle	O
panel	O
showed	O
the	O
hemocyte	O
nucleus	O
location	O
(	O
Blue	O
),	O
and	O
the	O
right	O
panel	O
showed	O
the	O
merge	O
of	O
previous	O
two	O
panels	O
.	O

Bar	O
=	O
20	O
µm	O
.	O

MjGal	B-GP
Promoted	O
Phagocytosis	O
of	O
Bacteria	B-OG
by	O
Hemocytes	O

The	O
above	O
results	O
showed	O
that	O
rMjGal	B-GP
could	O
bind	O
to	O
the	O
hemocyte	O
surface	O
and	O
to	O
G	O
+	O
and	O
G	O
−	O
bacteria	B-OG
,	O
presumably	O
by	O
binding	O
to	O
LTA	O
and	O
LPS	O
,	O
respectively	O
.	O

In	O
order	O
to	O
further	O
investigate	O
its	O
function	O
upon	O
binding	O
to	O
both	O
the	O
hemocytes	O
and	O
bacteria	B-OG
,	O
an	O
in	O
vivo	O
phagocytosis	O
assay	O
was	O
performed	O
.	O

The	O
results	O
revealed	O
that	O
almost	O
30	O
%	O
of	O
the	O
hemocytes	O
were	O
involved	O
in	O
phagocytosis	O
in	O
the	O
MjGal	B-GP
coated	O
group	O
,	O
while	O
only	O
10	O
%	O
in	O
the	O
control	O
group	O
(	O
Fig	O
.	O
8C	O
).	O

As	O
compared	O
with	O
the	O
control	O
group	O
(	O
Fig	O
.	O
8A	O
),	O
hemocytes	O
in	O
test	O
group	O
(	O
Fig	O
.	O
8B	O
)	O
phagocytosed	O
more	O
bacteria	B-OG
.	O

These	O
results	O
suggested	O
that	O
binding	O
of	O
MjGal	B-GP
to	O
hemocytes	O
and	O
/	O
or	O
bacteria	B-OG
in	O
vivo	O
promoted	O
their	O
phagocytosis	O
,	O
and	O
led	O
to	O
propose	O
the	O
hypothesis	O
that	O
MjGal	B-GP
enhances	O
the	O
clearance	O
of	O
potential	O
microbial	O
pathogens	O
from	O
circulation	O
.	O

MjGal	B-GP
promoted	O
bacterial	O
clearance	O
from	O
hemolymph	O
.	O

Bacteria	B-OG
phagocytosis	O
assay	O
:	O
fluorescently	O
labeled	O
V	B-OG
.	I-OG
anguillarum	I-OG
(	O
5	O
×	O
107	O
cells	O
)	O
were	O
coated	O
with	O
either	O
Trx	B-GP
-	O
His	O
(	O
A	O
,	O
the	O
control	O
)	O
or	O
rMjGal	B-GP
(	O
B	O
)	O
and	O
injected	O
into	O
shrimp	B-OG
.	O

The	O
hemocytes	O
were	O
collected	O
after	O
30	O
min	O
and	O
placed	O
onto	O
the	O
glass	O
slides	O
.	O

Subsequently	O
,	O
trypan	O
blue	O
solution	O
(	O
2	O
mg	O
/	O
ml	O
PBS	O
)	O
(	O
Amresco	O
)	O
was	O
added	O
to	O
quench	O
the	O
fluorescence	O
of	O
non	O
-	O
phagocytosed	O
bacteria	B-OG
.	O

The	O
phagocytosis	O
by	O
hemocytes	O
was	O
observed	O
at	O
400	O
×	O
magnification	O
,	O
and	O
phagocytosed	O
bacteria	B-OG
counted	O
at	O
200	O
×	O
magnification	O
under	O
the	O
fluorescence	O
microscope	O
.	O

(	O
A	O
)	O
Hemocytes	O
from	O
shrimp	B-OG
injected	O
with	O
V	B-OG
.	I-OG
anguillarum	I-OG
coated	O
with	O
Trx	B-GP
-	O
His	O
.	O

(	O
B	O
)	O
Hemocytes	O
from	O
shrimp	B-OG
injected	O
with	O
V	B-OG
.	I-OG
anguillarum	I-OG
coated	O
with	O
rMjGal	B-GP
.	O

(	O
C	O
)	O
The	O
phagocytic	O
percentages	O
of	O
two	O
groups	O
(*	O
P	O
<	O
0	O
.	O
05	O
).	O

Bar	O
=	O
50	O
µm	O
.	O

(	O
D	O
)	O
RNA	O
interference	O
assay	O
:	O
shrimp	B-OG
were	O
injected	O
with	O
dsRNAs	O
twice	O
to	O
silence	O
MjGal	B-GP
expression	O
,	O
and	O
or	O
with	O
GFP	B-GP
dsRNAs	O
as	O
control	O
.	O
Vibrio	B-OG
anguillarum	I-OG
(	O
2	O
×	O
107	O
cells	O
)	O
were	O
injected	O
into	O
shrimp	B-OG
after	O
the	O
second	O
injection	O
.	O

Hemolymph	O
was	O
collected	O
from	O
the	O
two	O
groups	O
at	O
5	O
,	O
15	O
,	O
60	O
min	O
post	O
-	O
infection	B-DS
,	O
and	O
serially	O
diluted	O
with	O
PBS	O
.	O

Fifty	O
µl	O
of	O
each	O
sample	O
was	O
plated	O
onto	O
2216E	O
agar	O
plates	O
and	O
incubated	O
at	O
37	O
°	O
C	O
overnight	O
.	O

RNA	O
was	O
extracted	O
from	O
hemocytes	O
and	O
gills	O
of	O
two	O
groups	O
,	O
and	O
tested	O
by	O
RT	O
-	O
PCR	O
to	O
confirm	O
silencing	O
of	O
MjGal	B-GP
expression	O
.	O

(	O
E	O
)	O
The	O
bacterial	O
counts	O
in	O
hemolymph	O
samples	O
collected	O
at	O
5	O
,	O
15	O
and	O
60	O
min	O
from	O
shrimp	B-OG
from	O
the	O
dsMjGal	O
and	O
dsGFP	O
groups	O
.	O

Silencing	O
of	O
MjGal	B-GP
Expression	O
Reduced	O
Bacterial	O
Clearance	O

To	O
test	O
the	O
hypothesis	O
on	O
the	O
role	O
of	O
MjGal	B-GP
in	O
immune	O
defense	O
based	O
the	O
above	O
observations	O
,	O
RNAi	O
was	O
performed	O
for	O
further	O
functional	O
analysis	O
of	O
MjGal	B-GP
.	O

Results	O
from	O
RT	O
-	O
PCR	O
demonstrated	O
that	O
that	O
injection	O
of	O
MjGal	B-GP
dsRNA	O
could	O
significantly	O
inhibit	O
mRNA	O
levels	O
of	O
MjGal	B-GP
in	O
hemocytes	O
(	O
Fig	O
.	O
8D	O
).	O

The	O
injection	O
of	O
bacteria	B-OG
into	O
the	O
MjGal	B-GP
-	O
silenced	O
shrimp	B-OG
and	O
control	O
animals	B-OG
that	O
had	O
been	O
injected	O
with	O
GFP	B-GP
dsRNA	O
revealed	O
that	O
the	O
numbers	O
of	O
bacteria	B-OG
in	O
the	O
hemolymph	O
of	O
MjGal	B-GP
-	O
silenced	O
shrimp	B-OG
were	O
significantly	O
higher	O
than	O
in	O
the	O
GFP	B-GP
dsRNA	O
-	O
injected	O
group	O
at	O
5	O
min	O
and	O
60	O
min	O
(	O
Fig	O
.	O
8E	O
).	O

These	O
results	O
confirmed	O
that	O
MjGal	B-GP
plays	O
a	O
key	O
role	O
in	O
the	O
shrimp	B-OG
defense	O
against	O
bacterial	O
infectious	O
challenge	O
.	O

Discussion	O

Although	O
galectins	B-GP
were	O
initially	O
described	O
as	O
developmentally	O
regulated	O
in	O
their	O
expression	O
and	O
playing	O
key	O
roles	O
in	O
early	O
embryogenesis	O
,	O
cell	O
differentiation	O
,	O
and	O
tissue	O
organization	O
,	O
in	O
recent	O
years	O
evidence	O
has	O
accumulated	O
in	O
support	O
of	O
their	O
participation	O
in	O
regulation	O
of	O
immune	O
homeostasis	O
by	O
modulating	O
inflammation	O
and	O
multiple	O
aspects	O
of	O
innate	O
and	O
adaptive	O
immunity	O
,	O
including	O
leukocyte	O
chemotaxis	O
,	O
migration	O
and	O
activation	O
[	O
29	O
],	O
B	O
cell	O
development	O
[	O
9	O
],	O
[	O
30	O
],	O
T	O
cell	O
apoptosis	O
[	O
8	O
],	O
[	O
31	O
],	O
and	O
other	O
regulatory	O
aspects	O
of	O
the	O
immune	O
responses	O
of	O
vertebrates	B-OG
[	O
7	O
]–[	O
12	O
].	O

Further	O
,	O
during	O
the	O
past	O
few	O
years	O
it	O
has	O
become	O
increasingly	O
clear	O
that	O
galectins	B-GP
also	O
bind	O
glycans	O
on	O
the	O
surface	O
of	O
potentially	O
pathogenic	O
microbes	B-OG
and	O
can	O
function	O
as	O
pattern	B-GP
recognition	I-GP
receptors	I-GP
(	O
PRRs	B-GP
)	O
[	O
13	O
].	O

Therefore	O
,	O
in	O
vertebrates	B-OG
,	O
galectins	B-GP
can	O
regulate	O
immune	O
functions	O
by	O
binding	O
to	O
both	O
endogenous	O
(‘	O
self	O
’)	O
glycans	O
,	O
and	O
microbe	B-OG
-	O
associated	O
(‘	O
non	O
-	O
self	O
’)	O
glycotopes	O
.	O

Although	O
in	O
invertebrates	B-OG
,	O
galectins	B-GP
are	O
thought	O
to	O
participate	O
in	O
those	O
biological	O
processes	O
that	O
are	O
common	O
to	O
vertebrates	B-OG
,	O
relatively	O
few	O
studies	O
have	O
documented	O
their	O
binding	O
to	O
self	O
and	O
non	O
-	O
self	O
glycans	O
and	O
any	O
role	O
(	O
s	O
)	O
in	O
immune	O
function	O
comparable	O
to	O
those	O
from	O
vertebrates	B-OG
.	O

Moreover	O
,	O
galectins	B-GP
have	O
been	O
described	O
only	O
in	O
a	O
few	O
crustacean	B-OG
species	O
,	O
including	O
the	O
Chinese	B-OG
mitten	I-OG
crab	I-OG
E	B-OG
.	I-OG
sinensis	I-OG
(	O
GenBank	O
:	O
ADF32023	O
.	O
1	O
),	O
the	O
Pacific	B-OG
white	I-OG
shrimp	I-OG
,	O
Litopenaeus	B-OG
vannamei	I-OG
(	O
GenBank	O
:	O
AGV04659	O
.	O
1	O
),	O
and	O
the	O
water	B-OG
flea	I-OG
D	B-OG
.	I-OG
pulex	I-OG
(	O
GenBank	O
:	O
AFI40275	O
.	O
1	O
).	O

These	O
studies	O
,	O
however	O
,	O
have	O
been	O
mostly	O
limited	O
to	O
the	O
identification	O
of	O
galectin	B-GP
transcripts	O
,	O
with	O
no	O
further	O
analysis	O
of	O
their	O
biological	O
role	O
(	O
s	O
).	O

Therefore	O
,	O
the	O
functional	O
characterization	O
of	O
crustacean	B-OG
galectins	B-GP
warrants	O
further	O
investigation	O
.	O

In	O
this	O
study	O
,	O
we	O
identified	O
and	O
functionally	O
characterized	O
for	O
the	O
first	O
time	O
a	O
novel	O
galectin	B-GP
from	O
the	O
kuruma	B-OG
shrimp	I-OG
,	O
M	B-OG
.	I-OG
japonicus	I-OG
.	O
The	O
shrimp	B-OG
galectin	B-GP
is	O
upregulated	O
by	O
infectious	O
challenge	O
,	O
and	O
can	O
recognize	O
and	O
opsonize	O
potentially	O
pathogenic	O
bacteria	B-OG
by	O
binding	O
to	O
the	O
hemocyte	O
surface	O
and	O
promoting	O
phagocytosis	O
,	O
and	O
silencing	O
of	O
its	O
expression	O
in	O
vivo	O
results	O
in	O
reduced	O
bacterial	O
clearance	O
rates	O
in	O
hemolymph	O
,	O
suggesting	O
that	O
MjGal	B-GP
plays	O
a	O
key	O
role	O
in	O
immune	O
defense	O
against	O
bacterial	B-DS
infection	I-DS
.	O

A	O
search	O
of	O
our	O
M	B-OG
.	I-OG
japonicus	I-OG
EST	O
database	O
revealed	O
a	O
transcript	O
that	O
we	O
designated	O
MjGal	B-GP
with	O
homology	O
to	O
members	O
of	O
the	O
galectin	B-GP
family	O
,	O
encoding	O
a	O
333	O
-	O
amino	O
acid	O
long	O
protein	O
of	O
33	O
.	O
5	O
kDa	O
apparent	O
mass	O
that	O
displays	O
a	O
single	O
127	O
-	O
residue	O
long	O
galactoside	O
-	O
binding	O
lectin	B-GP
domain	O
located	O
in	O
the	O
N	O
-	O
terminal	O
half	O
of	O
the	O
polypeptide	O
chain	O
.	O

The	O
primary	O
structural	O
organization	O
of	O
the	O
transcript	O
indicated	O
that	O
it	O
does	O
not	O
fit	O
the	O
canonical	O
features	O
of	O
the	O
proto	O
or	O
chimera	O
type	O
galectins	B-GP
from	O
vertebrates	B-OG
[	O
14	O
].	O

Although	O
the	O
MW	O
of	O
MjGal	B-GP
would	O
suggest	O
that	O
it	O
is	O
related	O
to	O
the	O
latter	O
galectin	B-GP
type	O
,	O
the	O
location	O
of	O
the	O
CRD	O
is	O
opposite	O
to	O
the	O
vertebrate	B-OG
representatives	O
,	O
in	O
which	O
the	O
CRD	O
is	O
located	O
closer	O
to	O
the	O
C	O
-	O
terminal	O
region	O
[	O
14	O
].	O

In	O
contrast	O
,	O
the	O
organization	O
of	O
the	O
MjGal	B-GP
transcript	O
is	O
quite	O
similar	O
to	O
the	O
galectin	B-GP
DpGal	B-GP
-	I-GP
2	I-GP
,	O
from	O
the	O
water	B-OG
flea	I-OG
D	B-OG
.	I-OG
pulex	I-OG
that	O
houses	O
a	O
127	O
-	O
amino	O
acid	O
long	O
CRD	O
linked	O
to	O
a	O
low	O
complexity	O
region	O
.	O

Analysis	O
of	O
the	O
nucleotide	O
and	O
deduced	O
amino	O
acid	O
sequences	O
indicated	O
a	O
closest	O
similarity	O
to	O
galectins	B-GP
identified	O
in	O
the	O
shrimp	B-OG
L	B-OG
.	I-OG
vannamei	I-OG
and	O
the	O
crab	B-OG
E	B-OG
.	I-OG
sinensis	I-OG
,	O
but	O
in	O
spite	O
of	O
the	O
similar	O
transcript	O
organization	O
,	O
a	O
significantly	O
lower	O
sequence	O
similarity	O
.	O

This	O
may	O
be	O
due	O
to	O
the	O
proposed	O
rapid	O
adaptive	O
evolution	O
of	O
immune	O
genes	O
in	O
Daphnia	B-OG
[	O
23	O
]	O
that	O
has	O
resulted	O
galectin	B-GP
sequences	O
that	O
are	O
substantially	O
divergent	O
from	O
other	O
crustacean	B-OG
species	O
.	O

A	O
phylogenetic	O
analysis	O
indicated	O
that	O
MjGal	B-GP
clustered	O
with	O
galectins	B-GP
from	O
invertebrates	B-OG
and	O
a	O
hemichordate	B-OG
,	O
and	O
was	O
clearly	O
distinct	O
from	O
the	O
vertebrate	B-OG
galectins	B-GP
group	O
.	O

MjGal	B-GP
was	O
expressed	O
in	O
all	O
tissues	O
tested	O
in	O
the	O
naïve	O
animals	B-OG
,	O
and	O
upon	O
infectious	O
challenge	O
,	O
MjGal	B-GP
expression	O
was	O
significantly	O
upregulated	O
in	O
both	O
hemocytes	O
and	O
hepatopancreas	O
.	O

In	O
crustaceans	B-OG
,	O
most	O
C	B-GP
-	I-GP
type	I-GP
lectins	I-GP
involved	O
in	O
immune	O
function	O
are	O
expressed	O
in	O
the	O
hepatopancreas	O
and	O
released	O
to	O
the	O
circulation	O
[	O
32	O
].	O

Furthermore	O
,	O
the	O
crustacean	B-OG
hemocytes	O
are	O
involved	O
in	O
various	O
aspects	O
of	O
surveillance	O
and	O
cellular	O
immune	O
responses	O
[	O
32	O
].	O

Taken	O
together	O
,	O
these	O
results	O
strongly	O
suggested	O
that	O
MjGal	B-GP
might	O
be	O
involved	O
in	O
antibacterial	O
responses	O
.	O

This	O
was	O
confirmed	O
by	O
in	O
vivo	O
bacterial	O
clearance	O
experiments	O
that	O
showed	O
that	O
bacteria	B-OG
that	O
had	O
been	O
pre	O
-	O
incubated	O
with	O
MjGal	B-GP
and	O
injected	O
into	O
shrimp	B-OG
were	O
cleared	O
more	O
rapidly	O
from	O
circulation	O
than	O
those	O
exposed	O
to	O
the	O
control	O
protein	O
or	O
buffer	O
alone	O
.	O

Although	O
the	O
role	O
of	O
invertebrate	B-OG
lectins	B-GP
(	O
particularly	O
of	O
the	O
C	O
-	O
type	O
)	O
in	O
pathogen	O
clearance	O
has	O
been	O
demonstrated	O
for	O
several	O
species	O
,	O
particularly	O
insects	B-OG
[	O
32	O
]	O
and	O
mollusks	B-OG
[	O
15	O
],	O
this	O
is	O
the	O
first	O
demonstration	O
in	O
a	O
crustacean	B-OG
species	O
that	O
a	O
galectin	B-GP
can	O
promote	O
bacterial	O
clearance	O
and	O
contribute	O
to	O
immune	O
defense	O
against	O
microbial	O
pathogens	O
.	O

To	O
elucidate	O
the	O
mechanisms	O
involved	O
in	O
bacterial	O
clearance	O
,	O
we	O
investigated	O
whether	O
MjGal	B-GP
directly	O
recognized	O
and	O
bound	O
to	O
the	O
bacterial	O
surface	O
.	O
MjGal	B-GP
bound	O
strongly	O
to	O
both	O
G	O
+	O
and	O
G	O
−	O
bacteria	B-OG
,	O
in	O
a	O
manner	O
that	O
could	O
be	O
partially	O
or	O
totally	O
inhibited	O
by	O
LPS	O
or	O
LTA	O
,	O
respectively	O
.	O

However	O
,	O
although	O
the	O
binding	O
could	O
not	O
be	O
inhibited	O
or	O
outcompeted	O
by	O
lactose	O
,	O
a	O
typical	O
galectin	B-GP
ligand	O
,	O
but	O
could	O
be	O
displaced	O
by	O
a	O
detergent	O
such	O
as	O
SDS	O
.	O

In	O
contrast	O
,	O
MjGal	B-GP
also	O
bound	O
strongly	O
to	O
the	O
hemocyte	O
surface	O
,	O
but	O
the	O
binding	O
could	O
be	O
inhibited	O
(	O
at	O
least	O
partially	O
)	O
by	O
lactose	O
,	O
thereby	O
confirming	O
that	O
like	O
most	O
galectins	B-GP
described	O
to	O
date	O
,	O
MjGal	B-GP
binds	O
to	O
galactosyl	O
moieties	O
.	O

Thus	O
,	O
the	O
lack	O
of	O
inhibitory	O
effect	O
of	O
lactose	O
on	O
the	O
binding	O
of	O
MjGal	B-GP
to	O
bacteria	B-OG
requires	O
alternative	O
explanations	O
.	O

First	O
,	O
due	O
to	O
the	O
bacterial	O
oligosaccharide	O
structures	O
or	O
the	O
architecture	O
of	O
their	O
presentation	O
on	O
the	O
microbial	O
surface	O
,	O
MjGal	B-GP
may	O
bind	O
with	O
higher	O
affinity	O
to	O
microbial	O
surface	O
glycans	O
relative	O
to	O
lactose	O
,	O
which	O
is	O
not	O
able	O
to	O
outcompete	O
the	O
interactions	O
even	O
at	O
high	O
concentrations	O
.	O

These	O
glycans	O
would	O
be	O
different	O
from	O
those	O
displayed	O
on	O
the	O
hemocyte	O
surface	O
,	O
to	O
which	O
MjGal	B-GP
would	O
bind	O
in	O
a	O
lactose	O
-	O
inhibitable	O
manner	O
.	O

Second	O
,	O
it	O
is	O
also	O
possible	O
that	O
upon	O
binding	O
of	O
MjGal	B-GP
to	O
the	O
microbial	O
cell	O
surface	O
,	O
a	O
considerable	O
disruption	O
of	O
bacterial	O
membrane	O
morphology	O
takes	O
place	O
thereby	O
exposing	O
areas	O
that	O
establish	O
secondary	O
interactions	O
(	O
ie	O
hydrophobic	O
)	O
with	O
MjGal	B-GP
that	O
are	O
different	O
from	O
the	O
initial	O
protein	O
-	O
carbohydrate	O
interactions	O
.	O

Displacement	O
of	O
these	O
additional	O
MjGal	B-GP
-	O
bacteria	B-OG
interactions	O
would	O
require	O
a	O
detergent	O
such	O
as	O
SDS	O
,	O
as	O
observed	O
in	O
our	O
experiments	O
.	O

The	O
disruption	O
of	O
membrane	O
morphology	O
in	O
both	O
prokaryotic	O
and	O
eukaryotic	O
cells	O
upon	O
binding	O
of	O
galectins	B-GP
has	O
been	O
reported	O
elsewhere	O
[	O
29	O
],	O
[	O
33	O
],	O
[	O
34	O
].	O

Both	O
human	B-OG
Gal	B-GP
-	I-GP
4	I-GP
and	O
Gal	B-GP
-	I-GP
8	I-GP
directly	O
kill	O
BGB	O
+	O
E	B-OG
.	I-OG
coli	I-OG
through	O
recognition	O
of	O
bacterial	O
surface	O
carbohydrates	O
via	O
a	O
mechanism	O
that	O
drastically	O
alters	O
membrane	O
integrity	O
and	O
bacterial	O
motility	O
[	O
33	O
].	O

Solid	O
phase	O
binding	O
experiments	O
showed	O
that	O
both	O
LTA	O
and	O
LPS	O
,	O
but	O
not	O
PGN	O
,	O
can	O
be	O
potential	O
targets	O
for	O
MjGal	B-GP
-	O
mediated	O
recognition	O
of	O
the	O
surface	O
of	O
G	O
+	O
and	O
G	O
−	O
bacteria	B-OG
,	O
respectively	O
.	O

The	O
binding	O
of	O
bacterial	O
glycans	O
by	O
invertebrate	B-OG
lectins	B-GP
has	O
been	O
described	O
for	O
insect	O
and	O
mollusks	B-OG
,	O
with	O
LPS	O
and	O
PGN	O
being	O
the	O
more	O
frequently	O
recognized	O
targets	O
[	O
13	O
],	O
[	O
35	O
].	O

Kinetic	O
analysis	O
of	O
the	O
MjGal	B-GP
binding	O
to	O
the	O
for	O
LPS	O
and	O
LTA	O
suggest	O
that	O
MjGal	B-GP
affinities	O
for	O
these	O
glycans	O
are	O
different	O
,	O
although	O
it	O
is	O
likely	O
that	O
its	O
capacity	O
for	O
recognition	O
will	O
depend	O
on	O
their	O
density	O
,	O
presentation	O
,	O
and	O
distribution	O
on	O
the	O
microbial	O
surface	O
.	O

This	O
,	O
as	O
well	O
as	O
the	O
detailed	O
structural	O
aspects	O
of	O
the	O
interactions	O
that	O
will	O
enable	O
to	O
explain	O
the	O
different	O
affinities	O
warrants	O
further	O
investigation	O
.	O

The	O
mutant	O
rMjGalΔ102	O
–	O
106	O
in	O
which	O
two	O
conserved	O
cysteine	O
residues	O
and	O
three	O
additional	O
residues	O
in	O
the	O
CRD	O
were	O
deleted	O
,	O
showed	O
a	O
relatively	O
weaker	O
binding	O
activity	O
for	O
bacteria	B-OG
,	O
LPS	O
or	O
LTA	O
,	O
than	O
that	O
of	O
the	O
wild	O
type	O
rMjGal	B-GP
.	O

This	O
confirmed	O
that	O
the	O
binding	O
of	O
rMjGal	B-GP
to	O
the	O
ligands	O
tested	O
takes	O
place	O
via	O
the	O
five	O
canonical	O
amino	O
acid	O
residues	O
in	O
the	O
CRD	O
,	O
but	O
also	O
suggests	O
that	O
other	O
amino	O
acid	O
residues	O
in	O
an	O
extended	O
CRD	O
might	O
contribute	O
to	O
the	O
lectin	B-GP
-	O
ligand	O
interaction	O
.	O

The	O
functional	O
outcome	O
of	O
the	O
binding	O
of	O
MjGal	B-GP
to	O
both	O
microbial	O
pathogens	O
and	O
the	O
shrimp	B-OG
hemocyte	O
surface	O
was	O
the	O
enhancement	O
of	O
phagocytosis	O
of	O
bacteria	B-OG
by	O
the	O
hemocytes	O
,	O
as	O
experimentally	O
demonstrated	O
in	O
vivo	O
.	O

This	O
opsonic	O
effect	O
of	O
MjGal	B-GP
for	O
bacteria	B-OG
that	O
may	O
have	O
invaded	O
the	O
shrimp	B-OG
internal	O
milieu	O
became	O
the	O
rationale	O
to	O
propose	O
the	O
hypothesis	O
that	O
MjGal	B-GP
-	O
mediated	O
opsonization	O
might	O
be	O
the	O
mechanism	O
by	O
which	O
MjGal	B-GP
enhances	O
the	O
clearance	O
of	O
potential	O
microbial	O
pathogens	O
from	O
circulation	O
as	O
initially	O
observed	O
.	O

The	O
oyster	B-OG
galectin	B-GP
CvGal1	B-GP
binds	O
to	O
the	O
surface	O
of	O
a	O
variety	O
of	O
microbes	B-OG
as	O
well	O
as	O
the	O
parasite	O
Perkinsus	B-OG
marinus	I-OG
and	O
the	O
pre	O
-	O
incubation	O
of	O
hemocytes	O
with	O
and	O
anti	O
-	O
CvGal1	B-GP
antibody	B-GP
significantly	O
reduced	O
phagocytosis	O
,	O
thus	O
confirming	O
that	O
hemocyte	O
surface	O
-	O
bound	O
CvGal1	B-GP
participated	O
in	O
the	O
uptake	O
of	O
cross	O
-	O
linked	O
microbes	B-OG
[	O
15	O
].	O

As	O
MjGal	B-GP
can	O
bind	O
to	O
both	O
the	O
microbial	O
and	O
the	O
hemocyte	O
surface	O
,	O
it	O
is	O
possible	O
that	O
MjGal	B-GP
functions	O
in	O
a	O
similar	O
way	O
to	O
CvGal1	B-GP
,	O
as	O
a	O
receptor	O
on	O
the	O
surface	O
of	O
hemocytes	O
or	O
as	O
a	O
soluble	O
opsonin	O
to	O
promote	O
phagocytosis	O
.	O

The	O
MjGal	B-GP
RNAi	O
silencing	O
experiments	O
rigorously	O
tested	O
this	O
hypothesis	O
in	O
vivo	O
,	O
and	O
revealed	O
the	O
numbers	O
of	O
bacteria	B-OG
in	O
the	O
hemolymph	O
of	O
MjGal	B-GP
-	O
knockdown	O
shrimp	B-OG
were	O
significantly	O
higher	O
than	O
in	O
the	O
control	O
groups	O
,	O
particularly	O
during	O
the	O
acute	O
phase	O
around	O
the	O
first	O
5	O
min	O
,	O
thereby	O
confirming	O
that	O
MjGal	B-GP
plays	O
a	O
key	O
role	O
in	O
the	O
bacterial	O
clearance	O
from	O
shrimp	B-OG
hemolymph	O
and	O
therefore	O
,	O
in	O
the	O
animal	B-OG
’	O
s	O
defense	O
against	O
bacterial	B-DS
infection	I-DS
.	O

This	O
study	O
is	O
the	O
first	O
demonstration	O
of	O
the	O
biological	O
role	O
of	O
a	O
crustacean	B-OG
galectin	B-GP
in	O
the	O
innate	O
immune	O
response	O
against	O
infectious	O
challenge	O
.	O

